The News Magazine of the American Association of Colleges of Pharmacy
Academic Pharmacy NOW Fall 2012
Volume 5 Issue 3
Retooling the Research Pipeline How can we turn up the flow of faculty investigators and innovations? 14 18 Managed Care: A Balancing Act 22 Megadoses of Learning at the AACP Annual Meeting
American Association of Colleges of Pharmacy Discover 路 Learn 路 Care : Improve Health
Academic Pharmacy NOW Fall 2012
Volume 5 Issue 3
Departments 5 News Briefs 9 Academy in Action • Active Advocacy…Deep in the Heart of Texas
• Innovative Strategies to Reach Patients Pay Off
• Teaming Up to Teach Pain Management
12 Around the World • New Partnership Forged • A Fond Farewell
31 Faculty News 43 The Last Word • Pharmacy Graduating
Features 14 Retooling the Research Pipeline By Vincent Lau, Ph.D. Can we turn up the flow of faculty investigators and continue the innovations required to keep our country competitive? Let’s work together on this laborious process.
18 The Complex Balance of Managed Care By Edith A. Rosato, R.Ph., IOM The Academy of Managed Care Pharmacy’s CEO talks about improving patient health while controlling costs.
22 A Large Dose of Learning By Gerry Romano, Maureen Thielemans and Kelley Ratermann Pharmacy educators engaged in professional development on a grand scale at the 2012 AACP Annual Meeting.
Student Survey: Required Interprofessional Education
Columns 3 Publisher’s Note By Lucinda L. Maine 8 Will on the Hill A Lite-r Approach By William G. Lang
academic Pharmacy now Fall 2012
Dear Colleagues: How effectively are we preparing student pharmacists for their roles in the real world? That ever-burning question was addressed by a survey shared at the September ACPE Summit, Advancing Quality in Pharmacy Education: Charting Accreditation’s Future. The report said that, on balance, ACPE-accredited Pharm.D. programs are doing well in preparing graduates for activities related to medication use, patient care and systems management. The curricula designed in accordance with existing ACPE standards appear to be achieving the Center for the Advancement of Pharmaceutical Education (CAPE) competency framework of patient care, systems management and public health. Attending the summit, I especially enjoyed hearing keynoter University of Maryland President Jay A. Perman, M.D., focus on the imperative for reform in health professions education and practice. His takeaway message: Our graduates unequivocally must be team-ready when they leave our programs, or those programs will have failed the graduates, their employers and the patients they will serve. Interprofessional education that equips pharmacists to contribute to team-based care in all settings will, without a doubt, be a prominent theme for any subsequent ACPE standards revision. What happens following the summit, which included participation by six CAPE competency panel members, merits our full attention. The CAPE panel will produce its preliminary report before year end and will provide the Academy with a proposed framework for education. AACP will help disseminate the summit outcomes. One key opportunity for discussion will be at the 2013 Interim Meeting in San Juan, Puerto Rico. Meanwhile, the drum beats on the themes of collaboration, cooperation and accountability—all reflected in this issue of Academic Pharmacy Now. Edith A. Rosato, CEO at the Academy of Managed Care Pharmacy, notes that currently two out of three Americans receive healthcare in managed care systems. Pharmacists, physicians and other providers are making decisions jointly at the population and individual patient levels on how best to improve care. AACP Chief Science Officer Vincent Lau, Ph.D., paints a picture of a changing landscape for research in the United States. He believes that the most successful research programs ahead will require a great deal of interdisciplinary collaboration, including translational research, to advance practice. Happy reading—and please consider sharing your thoughts about these and other issues highlighted in the magazine. Sincerely,
Lucinda L. Maine, Ph.D., R.Ph. CEO and Publisher
academic Pharmacy now Fall 2012
American Association of Colleges of Pharmacy 1727 King Street Alexandria, VA 22314 Phone: 703-739-2330 • Fax: 703-836-8982 www.aacp.org
Academic Pharmacy NOW CEO & Publisher
Lucinda L. Maine Editorial Director
Founded in 1900, AACP is the national organization representing the interests of pharmacy education. The Association comprises 127 accredited colleges and schools of pharmacy, including more than 6,400 faculty, 60,000 students enrolled in professional programs and 5,100 individuals pursuing graduate study. Academic pharmacy will transform the future of healthcare to create a world of healthy people.
The mission of AACP is to lead and partner with our members in advancing pharmacy education, research, scholarship, practice and service to improve societal health. We will accomplish this mission by:
• • •
Providing forums for faculty development and networking. Disseminating cutting-edge pedagogy related to professional and graduate education. Fostering environments and stimulating the development of resources that support the research and scholarship of faculty. Creating leadership and advocacy skills development opportunities for members and students. Fostering development of innovative professional and graduate education programs, assessment, resources and strategies. Facilitating members’ development, evaluation and dissemination of new practice models through collaboration with other healthcare organizations and practitioners. Facilitating development of products, programs and services for members that create efficiencies and effectiveness, and enhance value. Ensuring the appropriate infrastructure and resources are in place to advance our mission. Providing advocacy for academic pharmacy. Supporting faculty and graduates dedicated to and equipped for life-long learning, utilizing models of continuing professional development.
firstname.lastname@example.org Art Director
William G. Lang
academic Pharmacy now Fall 2012
Director of Communications and Marketing
Letters to the Editor
We welcome your comments. Please submit all letters to the editor to email@example.com.
About Academic Pharmacy Now
Academic Pharmacy Now highlights the work of AACP member pharmacy schools and faculty. The magazine is published quarterly by AACP as a membership service.
To subscribe, visit http://www.aacp.org/news/shopaacp/ Pages/publications.aspx.
Change of Address
For address changes, contact Terry J. Ryan, Membership and Database Manager, at firstname.lastname@example.org.
For advertising rates, please visit http://www.aacp.org/ news/academicpharmnow/pages/advertisingwithaacp.aspx. ©2012 by the American Association of Colleges of Pharmacy. All rights reserved. Content may not be reprinted without prior written permission.
News Briefs Medication Adherence: There’s an App for That
ly from high school. Students who have completed sufficient prerequisite coursework or degrees will be permitted to transfer prior to the first professional year of the program.
Two Campbell University pharmacy faculty members created an app to screen patients for medication adherence issues. Developed by Associate Professor of Pharmacy Practice Penny Touro University California to Study Shelton, Pharm.D., and Ted Hancock, Pharm.D., assistant Tobacco Plants professor of pharmacy practice, the app presents the patient A Grand Challenges Explorations grant will help Touro Uniwith a series of 10 questions and calculates a risk score from 0 versity California pursue a research project that uses tobacco to 10. Three additional questions check for serious adherence plants to produce vaccines. Funded by the Bill & Melinda problems. If the score exceeds 2, or if any of the final three Gates Foundation, the Grand Challenges Explorations initiaquestions are issues, the app recommends that the patient re- tive supports individuals worldwide who are pursuing ideas to ceive a comprehensive evaluation by a senior care pharmacist. solve persistent global health and development challenges. A button on the results page brings up a directory of senior care pharmacists in the area. “Our goal is to develop a rapid and inexpensive way to make a new kind of vaccine in tobacco plants,” said Dr. Alison McThe app is available for $0.99 and includes free updates. Search Cormick, associate professor in the College of Pharmacy. “This “MedAdhIR” at Apple® and Google Play® stores to download goal is relevant to the Grand Challenges objective of improving the app. ‘synthetic biology’ by using a living plant system to create and assemble complex molecules.”
Prenatal Exposure to Chemicals Delays Puberty Pregnant women exposed to environmental contaminants risk long-term changes to the baby’s developing brain that have adverse effects on reproductive function later in life, a new study has found. Co-author Dr. Andrea Gore, professor of pharmacy/toxicology at The University of Texas at Austin, studied rats exposed to polychlorinated biphenyls, or PCBs, which are found in many plastics, insulation materials and floor finishes used before their ban in 1979. Rats’ genes and molecules in the hypothalamus—the region of the brain important for reproductive function—are virtually identical to those in humans. During the study, PCB-induced brain changes delayed puberty in male offspring and disrupted reproductive cycles in adult female offspring, Gore said. The researchers identified five genes that PCBs disrupted. Gore noted that all five are critical to the normal hypothalamic control of reproduction. “By identifying five genes that are most perturbed by PCBs in the developing rat brain,” she said, “we may one day be able to develop targeted interventions or therapeutics for reproductive problems, focusing on these molecular endpoints.”
St. Louis College of Pharmacy Launches 7-year Program Beginning with the 2014 academic year, St. Louis College of Pharmacy will expand its program from six to seven years. The new structure will let students receive a Bachelor of Science degree after four academic years. The college will maintain its direct admissions policy, which allows students to enter direct-
IPEC Announces Curricular Development Awardees Sixteen interprofessional teams will receive funding from the Interprofessional Education Collaborative (IPEC) to develop and submit educational content to MedEdPORTAL for peer review. These open-access instructional tools represent the beginning of a national clearinghouse of resources for interprofessional education and models of team-based or collaborative care. Two pharmacy schools were represented in the awards: Peter Colley, Pharm.D. candidate, class of 2013 at the University of California, San Francisco School of Pharmacy, for his project Improving Interdisciplinary Collaboration through Learner-Developed and Learner-Driven IPE Curriculum, and Edward F. Foote, Pharm.D., Wilkes University Nesbitt College of Pharmacy and Nursing, for his project Northeast/Central Pennsylvania Interprofessional Education Coalition (NECPA IPEC) Collaborative Care Summit. To learn more about these projects and the other awardees, visit www.mededportal.org/ipe.
New Members Begin Service on AJPE Editorial Board Three new members of the AJPE Editorial Board began threeyear terms in July. They are: Dr. Patrick C. Hardigan, Nova Southeastern University; Dr. Therese I. Poirier, Southern Illinois University Edwardsville; and Dr. Julie E. Szilagyi, University of Houston. Board members review manuscripts, write editorial Viewpoints and recommend to the Editor topics of interest to Journal readers.
academic Pharmacy now Fall 2012
JAPhA Article Evaluates Program Quality An article co-authored by AACP Executive Vice President and CEO, Lucinda L. Maine, Ph.D., R.Ph., in the Journal of the American Pharmacists Association (JAPhA) concluded that, to date, increases in the number of pharmacy programs and graduating students have not affected educational quality. Peter H. Vlasses, Pharm.D., executive director of the Accreditation Council for Pharmacy Education (ACPE), also contributed to the article. “AACP is enthusiastic about the work unfolding to increase the availability of measures to assess program quality and what’s called graduate fitness for practice,” Maine said. “We will continue to work with our members and other professional partners such as ACPE to meaningfully measure and assess quality within pharmacy education.” The article is available on the JAPhA Web site at http://www. japha.org/article.aspx?articleID=1216881.
In Memoriam Thomas J. Bardos Dr. Thomas J. Bardos, emeritus professor of medicinal chemistry at the University at Buffalo (UB), who was involved in cancer chemotherapy research for more than 50 years, died on May 15. He was a committed scientist, pioneer and educator, helping to ensure the continued progress of cancer research. During his tenure at UB, Bardos directed the thesis research of 32 Ph.D. candidates and the research projects of 38 postdoctoral associates. In 1995 he initiated and partially sponsored an annual national awards program with the American Association for Cancer Research for the selection of 10 advanced, undergraduate students to encourage their interest and training in cancer research. This successful program recently was renamed the AACR-Thomas J. Bardos Science Education Awards.
Kathleen Johnson Dr. Kathleen Johnson, vice dean of clinical affairs and outcomes sciences at the University of Southern California (USC) School of Pharmacy, died on July 24 in Bordeaux, France, resulting from injuries sustained in a fall. Johnson was a leader in the pharmacy profession whose career was marked by innovative projects. Her efforts were integral in the national movement to expand the role of the pharmacist as the medication expert on the healthcare team. Her work to improve medication use and safety generally—and for vulnerable, uninsured populations specifically—was honored with several national awards.
academic Pharmacy now Fall 2012
Joining the faculty in 1984 as an assistant professor, Johnson assumed the chair of the Titus Family Department of Clinical Pharmacy and Pharmaceutical Economics & Policy in 2006. In 2007 she was named the endowed chair in community pharmacy. She served on the task force of the University of California Office of the President-California Health Benefits Review Program, the editorial board of the Annals of Pharmacotherapy, and the medication therapy review advisory panel of the American Pharmacists Association.
William W. Tester William W. Tester, a longtime University of Iowa College of Pharmacy associate professor, died on May 2 at the age of 87. Tester was born and raised in the Duluth, Minnesota area, and went on to be a decorated paratrooper with the 101st Airborne Division’s Screaming Eagles. In 1949 he received a B.S. from Montana State University and earned a master’s degree in hospital pharmacy from The University of Iowa in 1951. Tester served as the director of hospital pharmacy services, assistant professor in hospital pharmacy, and director of the hospital pharmacy internship program from 1959 to 1964. In 1964 he joined the College of Pharmacy as associate professor and director of pharmaceutical service. Two years later he became the director of the Iowa Drug Information Service, where he remained until his retirement in 1975.
James E. Wynn Dr. James E. Wynn, dean of the South University School of Pharmacy, passed away on July 11 after a battle with appendiceal cancer. He received a B.S. in pharmacy in 1964 from the Medical College of Virginia and a Ph.D. in medicinal chemistry in 1969. Wynn took his first faculty position at the College of Pharmacy at the University of South Carolina, where by 1977 he had achieved the academic rank of full professor with tenure. In 1982 Wynn joined the College of Pharmacy at the Medical University of South Carolina where, over the next 20 years, he served as a tenured professor of pharmaceutical sciences, chairman of the Department of Pharmaceutical Sciences, and assistant dean for research and graduate education. In 2001 Wynn was appointed the founding dean of the South University School of Pharmacy in Savannah, Georgia.
Liaison International and AACP celebrate the 1st-Year launch of the PharmCAS Mobile Portal.
Powered by , PharmCAS Mobile Portal brings the PharmCAS Application experience to the applicants fingertips.
www.liaison-intl.com academic Pharmacy now ď‚§ Fall 2012
will on the hill
A Lite-r Approach Providers and payers gain traction in new managed care models. By William G. Lang
This edition of Academic Pharmacy Now includes reminders that the intent of the managed care insurance approach of the 1990s is reflected in the health system reform initiatives of today: improve quality and reduce cost. Today’s initiatives can be referred to as “managed care lite.” The difference this time is that our approach to reform is focused on enhancing the delivery of care, while also improving health and keeping people healthy. Provisions in the Affordable Care Act (PL 111148) authorize the creation of shared savings programs. This allows the Centers for Medicare and Medicaid Services, acting through the Center for Medicare and Medicaid Innovation, to establish programs for the development and implementation of accountable care organizations (ACO) and their partners, patient-centered medical homes (PCMH).
lish payment structures. These structures are important because they must facilitate payment for the entire team as well as determine additional or decreased payments based on quality measure performance. Included in the HEDIS measures are concepts developed by the Pharmacy Quality Alliance, of which many pharmacy faculty are active members. Through their participation in the alliance, faculty have opportunities to influence HEDIS and other performance measures, once again demonstrating that academic pharmacy serves as an important resource in shaping healthcare policy. William G. Lang is Vice President of Policy and Advocacy at AACP; email@example.com.
Everyone Plays a Role In the traditional context of paying for services rendered, insurance companies are no longer the primary driver for managing care—or denying care as some asserted—by controlling payment for service delivery. The new managed care lite approach places greater responsibility on the patient and their team of providers to improve care coordination, utilize evidence-based care approaches, and share health information through technology. Controlling costs is important, but the benefits of a team approach to care are impactful. They include reductions in preventable hospital readmissions, unnecessary and duplicate tests and treatments, and increased patient adherence to care plans. These benefits are realized through a delivery system that supports patient adherence to—and provider delivery of—evidence-based guidelines, recommendations and performance measures and standards. Payment frameworks are established in turn. Reorganized payment and delivery structures include the new managed care lite groups: ACOs and PCMHs. Payment to these entities is dependent on their performance against quality measures. Listen to a podcast with Dr. Charles Saunders, president for strategic diversification at Aetna, to gain a better understanding of the difference between managed care 1.0, 2.0 or even 3.0, and what he refers to as “enlightened managed care.”
Supporting a New System So where do these quality measures come from and what is the evidence-base for their creation? The Healthcare Effectiveness Data and Information Set (HEDIS), developed through the National Committee for Quality Assurance (NCQA), provide much of the quality framework that ACOs, medical homes and many payers, including Medicare and Medicaid, use to estab-
academic Pharmacy now Fall 2012
Resources Initiatives of the Centers for Medicare and Medicaid Services http://innovation.cms.gov/initiatives/index.html Accountable Care Organization (ACO) Watch BlogTalkRadio http://www.blogtalkradio.com/ acowatch/2012/09/18/this-week-in-accountablecare-with-charles-saunders-md National Committee for Quality Assurance http://www.ncqa.org/HomePage.aspx Healthcare Effectiveness Data and Information Set (HEDIS) http://www.ncqa.org/ HEDISQualityMeasurement.aspx National Committee for Quality Assurance 2013 ACO HEDIS Measures http://www.ncqa.org/Portals/0/HEDISQM/ HEDIS2013/ACO_Core_Measure_List_9.6.12.pdf Pharmacy Quality Alliance www.pqaalliance.org
academy in action
Active Advocacy…Deep in the Heart of Texas Pharmacy professors demonstrate their important roles as resources in the development of policy at all levels. Three University of Texas at Austin (UT Austin) faculty members served as experts to state lawmakers and the FDA earlier this year, citing their entrepreneurial experience and research to help influence key decision-making. Dr. James W. McGinity, professor and chair at the College of Pharmacy, represented the school at a Texas state legislature committee hearing on developing intellectual property discovered on Texas university campuses. The House Committee on Economic and Small Business Development was studying ways to encourage Texas universities to convert their research into revenue—through products, companies and jobs—which is something McGinity knows about firsthand. McGinity developed a drug-patented process that makes it more difficult for someone to break up OxyContin, which is being abused by people who break up and snort the drug. This patent accounted for about $11 million of the $26 million in last year’s revenue for UT Austin’s Office of Technology and Commercialization. In 2016, the patent—and the university’s revenue stream— will expire. McGinity estimated UT Austin could have earned nine times the $11 million in annual revenue if the university had created a startup instead of licensing the patent to Abbott Laboratories.
Investing Pays Off McGinity urged the legislature to provide “pre-venture capital”—or seed money—to support faculty-generated startups. That money would come before the state’s money from the Emerging Technology Fund that helps startups grow and expand. There is risk in spending tax dollars on startups. The rule of thumb for venture capitalists is that only 2 out of 10 investments make a profit. But the successes are so great—or at least the investors hope they are—as to offset any losses. “I think there are other entrepreneurs at UT who may not go out and borrow $1 million but, with help from the legislature, could have successful companies,” McGinity noted to the committee.
Putting an Opinion in Print In another advocacy initiative, fellow UT Austin faculty member Dr. Andrea Gore, and her husband Dr. David Crews, explained in a Huffington Post op-ed how the environment and humans have become contaminated by chemicals. Their viewpoint, “Our Contaminated World,” sought to make the FDA aware of the potential health dangers of the thousands of “endocrine-disrupting” chemicals that are common in the environment. The agency was deciding earlier this year whether to ban the use of bisphenol-A (BPA) in food and beverage packaging. “There is a long scientific history showing a link between exposure to endocrine disruptors and reproductive disorders such as infertility and early puberty,” the authors wrote. “Furthermore, the evidence is growing that the damage is much more widespread. In studies of animals, both in the lab and in the wild, these chemicals have been shown to increase the risk of various cancers, to contribute to obesity, and to influence the activity of neurotransmitters in the brain. In fact, there are even hints that exposure to the chemicals may have something to do with the dramatic rise in autism and mental disorders over the past few decades.” The FDA determined it will continue to allow the chemical BPA in food and beverage containers, much to the outcry of scientists like Gore and Crews. Despite this decision, Gore has continued her research on the effects of environmental exposure to chemicals in humans, which is highlighted in a News Brief on page 5. To read the op-ed in its entirety, visit http://www.huffingtonpost.com/ david-crews/bpa-ban_b_1363311.html.
academic Pharmacy now Fall 2012
academy in action
Innovative Strategies to Reach Patients Pay Off Two CMS grants will improve rural patient health and integrate pharmacists into safety-net clinics. Two grants from the U.S. Department of Health and Human Services’ Centers for Medicare and Medicaid Services (CMS) will help communities deliver care to underserved populations. The first, a three-year, $4.1 million grant from the Center for Medicare and Medicaid Innovation, will fund a medication management program in 23 rural Virginia counties. The program will be administered by Carilion New River Valley Medical Center, in partnership with the Virginia Commonwealth University (VCU) School of Pharmacy, Aetna Healthcare and CVS/Caremark. The second, a $12 million grant awarded to the University of Southern California (USC) School of Pharmacy, will bring pharmacists into safety-net clinics in Southern California as a way to improve medication adherence and safe and appropriate prescription drug use. The goal is to optimize patient health while reducing avoidable hospitalizations and emergency room visits.
More than 40 pharmacists from five rural hospitals, 17 primary care practices and multiple CVS pharmacies (in addition to Carilion New River Valley) will be trained in the collaborative pharmacist practice model, in which pharmacists play a more direct and active role with patients. Pharmacists in the IHARP program will be trained via independent study, handson workshops and individual mentoring. They will learn more about patient assessment for nonadherence to medication; strategies to improve adherence; how to identify and resolve medication-related problems; and motivational interviewing techniques to encourage patient lifestyle changes. Dr. Gary R. Matzke, VCU School of Pharmacy’s associate dean for clinical research and public policy, is co-principal investigator on the project, along with William Lee, director of pharmaceutical services for Carilion New River Valley and the Carilion Western Region hospitals. Together they will be responsible for initiating and directing the project; hiring staff and overseeing training; and monitoring and reporting the results. Matzke will supervise the development of patient-education literature on better control of chronic disease.
The awards are part of the CMS Health Care Innovation Challenge, a $1 billion fund created to provide grants to applicants with compelling new ideas to deliver better health, improved care and lower costs for Medicare, Medicaid and Children’s Health Insurance Program recipients. Out of 3,000 applica“This is a major step toward a new interprofessional healthcare tions, 81 projects received funding. model for rural Americans,” he said. The IHARP project will help save an estimated $4.3 million in healthcare costs during the three-year period.
“Pharmacists are remarkably underutilized in the U.S. healthcare system and this demonstration will test and evaluate the impact of using them in primary care settings.” —Dr. Geoffrey F. Joyce, USC School of Pharmacy
Cost-Effectively Improving Health Outcomes USC’s plan to integrate clinical pharmacy services into safetynet clinics for vulnerable populations has an added benefit: It will create an estimated 27 jobs and save $43 million over a three-year period.
“The project is designed to address both the widespread misuse of prescribed medications and the shortage of primary care providers in low-income populations,” said Dr. Geoffrey Reaching Rural Populations F. Joyce, principal investigator on the project and an associate The Improving Health for At-Risk Rural Patients (IHARP) professor in the USC School of Pharmacy. “Pharmacists are reproject aims to enhance medication therapy and chronic dis- markably underutilized in the U.S. healthcare system and this ease state management. That, in turn, will improve health and demonstration will test and evaluate the impact of using them reduce hospitalizations, emergency room visits and adverse in primary care settings.” drug events in patients with multiple chronic diseases.
academic Pharmacy now Fall 2012
academy in action
USC notes that, nationally, poor adherence to prescription drugs is reaching epidemic proportions, resulting in suboptimal health outcomes, preventable hospitalizations, higher risk of death and as much as $290 billion in avoidable medical spending each year. More than half of all Americans have one or more chronic diseases, and for 90 percent of these patients medications are the first line of treatment.
the School of Pharmacy’s vice chair for continuing professional development, credentialing and distance education. The project will eventually extend to AltaMed clinics in Los Angeles County. Additionally, working with the East Los Angeles Occupational Center pharmacy technician training program, the project will help develop curricula that supports expanded roles for pharmacy technicians.
USC will work with AltaMed Health Services, initially launching the project in three treatment clinics in Orange County. In many instances, these clinics are the only source of care for uninsured individuals with a high prevalence of uncontrolled diabetes, hypertension, asthma and heart disease. With pharmacists working collaboratively with physicians, the project aims to use evidence-based treatment regimens to improve patient care and health outcomes while reducing costs. A Web-based training/credentialing program for pharmacists to replicate the model will be led by co-investigator Dr. Jeffery A. Goad,
More information about the CMS Health Care Innovation Awards is available at http://innovations.cms.gov/initiatives/ Innovation-Awards/index.html.
The New AACP Online Learning Center Now that our Online Learning Center is complete with fresh new content from the 2012 Annual Meeting, we’ve decided it’s time for a new look! AACP is getting ready to launch the NEW Online Learning Center, making it easier for members to navigate session recordings, and access the school posters and educational and research posters presented at the meeting. Enjoy presentations from top speakers in pharmacy education and enrich your professional development with valuable education from AACP year-round. 2012 Annual Meeting attendees receive complimentary access to recordings from the Meeting. AACP members who were unable to attend the event can purchase access to session recordings for a discounted rate.
Access your educational session recordings now!
academic Pharmacy now Fall 2012
academy in action
Teaming Up to Teach Pain Management NIH Pain Consortium partners with health professional schools to address inconsistencies in chronic pain care. The National Institutes of Health (NIH) Pain Consortium selected 11 health professional schools as designated Centers of Excellence in Pain Education (CoEPEs), including the University of Maryland (UM) and Southern Illinois University Edwardsville (SIUE). The designations recognize pharmacists, and the institutions that educate them, as important players in the care coordination that is essential to pain management. The CoEPEs will act as hubs for developing, evaluating and distributing pain management curriculum resources for pharmacy, medical, dental and nursing schools. Their goal is to enhance and improve how healthcare professionals learn about pain and its treatment. The new centers will translate current research findings about pain management to fill what have been recognized as gaps in curricula so clinicians can work with their patients to make better and safer choices about pain treatment, according to Dr. Francis S. Collins, director of the NIH. Many of the CoEPEs will build curricula across several of their health professional schools.
Interprofessional Efforts Play a Critical Role Researchers from UM’s schools of pharmacy, medicine, nursing and dentistry are collaborating in the CoEPE. “We will be developing and posting a great curriculum for teaching interprofessional healthcare students and practitioners about pain management,” said Dr. Mary Lynn McPherson, co-principal investigator on the grant and professor of pharmacy practice and science at the School of Pharmacy. “Pain is a complex and emotional state—the management of total pain mandates the inclusion of multiple health professionals working in a collaborative fashion. Our training program will meet that need and provide educators with a menu of opportunities to implement in the United States and likely worldwide.” Chronic pain affects approximately 100 million Americans, costing up to $635 billion in medical treatment and lost productivity, and producing immeasurable suffering for people of every age. Yet, pain treatment is not taught extensively in many health professional schools, and clinical approaches can be inconsistent.
academic Pharmacy now Fall 2012
Supported by an NIH three-year grant, the curricula developed by the CoEPEs will advance the assessment, diagnosis and safe treatment of a variety of pain conditions and minimize the abuse of opioid pain relievers. Efforts by the University of Maryland and the other awardees will include teaching multiple case-based scenarios, many taught in video or electronic formats popularly used in contemporary academic settings. The NIH Pain Consortium is particularly interested in rehabilitation pain, arthritis and musculoskeletal pain, neuropathic pain and headache pain.
Understanding Patients’ Pain Southern Illinois University Edwardsville was among those selected as a CoEPE after a highly competitive contract solicitation process and review. Dr. Christopher M. Herndon, associate professor in the School of Pharmacy, led the grant application. “The subsequent impact [of this opportunity] on patient care for those in pain in our region will be immeasurable,” he said. Dr. Keith A. Hecht, Dr. Erin M. Timpe and Dr. McKenzie C. Ferguson from the School of Pharmacy will serve as co-investigators. The CoEPEs’ curricula will address the pathophysiology and pharmacology of pain and its treatment; the latest research in complementary and integrative pain management; factors that contribute to both under- and over-prescribing pain medications; and how pain manifests itself differently by gender, in children, in older adults and in diverse populations. Other AACP member schools receiving this designation are the University of Washington; The University of New Mexico; Thomas Jefferson University; the University of California, San Francisco; and the University of Pittsburgh.
around the world
New Partnership Forged ONU moves forward with plans in Ghana. Ohio Northern University’s (ONU) Raabe College of Pharmacy has begun an educational partnership with the Pharmacy Council of Ghana and the school of pharmacy at the Kwame Nkrumah University of Science and Technology (KNUST). Together they will implement a doctoral program of pharmacy in the West African country. The three groups will help KNUST transition its pharmacy education from the current bachelor’s degree to a Doctor of Pharmacy. The partnership was sparked by a West African Health Organization initiative—of which Ghana is the lead country—to standardize medical education and the standard of care. With the region’s most advanced social, educational and political structures, Ghana has been tasked in moving West Africa’s pharmacy education forward.
During the signing ceremony, T.C Fleischer, dean of pharmacy at KNUST, stressed the need for this important understanding with their counterpart from the United States. “ONU is poised to influence pharmacy care across a subcontinent,” said Dr. Jeffrey Talbot, assistant professor of pharmacology at ONU, who was instrumental in fostering this new partnership. “Our role is to provide guidance and expertise in three specific areas: to shape their doctoral curriculum, to contribute to the continuing education of pharmacists and to develop experiential learning for students.”
“Ghana is making the commitment as a nation to elevate the standard of care,” said Dr. Jon E. Sprague, dean of pharmacy at Ohio Northern University. “One of the most striking aspects of my visit to Ghana stemmed from my interactions with practicing pharmacists in hospital and community settings. From very different perspectives, they all expressed the same need for an increase in academic clinical training and for changes in pharmacy practice that allow them to apply these clinical skills.”
Above: Joseph Nyoagbe, registrar of Pharmacy Council of Ghana, Dr. Jon E. Sprague, dean of pharmacy at Ohio Northern University, and Peter Donkor, pro vice-chancellor of Kwame Nkrumah University of Science and Technology.
Right: Ton Hoek (left) received a joint letter of congratulations from AACP, AAPS, APhA and ASHP after being named an officer in the Order of Orange-Nassau, a royal declaration bestowed by the Queen of the Netherlands.
A Fond Farewell
The global pharmacy community mourns the loss of a leader. A.J.M. (Ton) Hoek, International Pharmaceutical Federation (FIP) CEO and general secretary, passed away on July 28 after a short but courageous battle with cancer. Hoek took the helm of FIP in 1999 and since that time brought the federation to new levels of development and accomplishment. He solidified key global partnerships with the World Health Organization and incorporated FIP as a founding partner in the World Health Professions Alliance. Hoek’s outreach efforts made FIP an influential global stakeholder in medications and health. His work also raised the image of the pharmacist as a healthcare provider around the world. He was named an officer in the Order of Orange-Nassau, a royal declaration bestowed by the Queen of the Netherlands.
The culmination of Hoek’s vision is evidenced in the events that will take place at the upcoming FIP Centennial Congress, including a Ministers Summit on The Responsible Use of Medicines, organized by the Dutch Ministry of Health. This dream was in the making for many years and will be realized to its fullest potential thanks to his efforts. “Ton set the bar for pharmacy in international affairs quite high, stating that ‘Whenever pharmaceuticals and their management are on the agenda, FIP will be at the table,’” commented Dr. Lucinda L. Maine, Ph.D., R.Ph., AACP executive vice president and CEO. “He will be sorely missed and long remembered.”
academic Pharmacy now Fall 2012
academic Pharmacy now ď‚§ Fall 2012
Research Pipeline By Vincent Lau, Ph.D.
Can we turn up the flow of faculty investigators and continue the innovations required to keep our country competitive? Let’s work together on this laborious process. We all know the challenge: Pharmacy institutions—especially those with small research programs—are having difficulty recruiting and retaining promising faculty investigators. What we may not realize—or, at least, like to think about—is this: If the pattern continues, U.S. competitiveness and innovation in biomedical research will suffer and the nation’s reputation for making discoveries and improving health will rapidly erode.
The current federal, state and institutional budgets for supporting biomedical research and graduate education are significantly less than they were a decade ago. The pending 2013 budget cuts mandated by the Congressional Budget Control Act of 2011 could further impede the country’s momentum regarding biomedical research and graduate education. Many pharmacy schools have already faced tough decisions and identified alternative measures to tighten their operational budgets. This economic situation affects all health professions and makes competition for funding even stiffer in an already inundated research arena.
academic Pharmacy now Fall 2012
Building Relationships Among Scientists To address the problem, the National Institutes of Health (NIH) tasked a Biomedical Research Workforce Working Group to develop a model for a sustainable and diverse U.S. biomedical research workforce. The group’s goal is to ensure that an optimal number of next-generation scientists will have the necessary resources and training to translate scientific discoveries into new treatments as quickly and effectively as possible to improve health. In a recently released draft report by the group, recommendations were made to the NIH and its grantee institutions concerning the training of graduate students and postdoctoral researchers. Pharmacy should take note too—the group’s suggestions would make AACP member institutions and faculty investigators highly competitive for federal funds. The report includes the following recommendations: • Institutions should collect data, such as time to earn a degree, completion rates and other measures, on the career outcomes of all graduate students and postdoctoral researchers. The information should be made available to prospective students. • Institutions should be encouraged to shorten the Ph.D. training period and diversify a trainee’s career development experiences to better prepare him or her for career options within and outside of academia. • Institutional graduate and postgraduate training programs should consider and value a broad range of career outcomes. Training students in a narrowly defined discipline and submitting research applications with limited scope are unlikely to be sustainable in this environment. The newly created National Center for Advancing Translational Sciences at NIH is focusing on linking basic science research with new treatments and clinical care. NCATS will emphasize strengthening collaborations between the biomedical industry and academia to accelerate the time it takes to transform scientific discoveries into viable treatments for patients. NIH also issued a funding opportunity announcement soliciting teams of non-NIH extramural scientists and NIH intramural investigators to conduct collaborative translational research projects. This provides outside scientists with opportunities to establish collaborations and explore potential partnerships with individuals working within NIH.
academic Pharmacy now Fall 2012
Radical Change Ahead Available resources will shift to accommodate new initiatives and directions, and pharmacy schools must modify their graduate education programs accordingly. New pharmaceutical scientists should be trained to work in teams and creatively assemble research programs with investigators who understand clinical needs and translate basic findings to clinical practice. This model will ensure a sustainable and diverse research workforce that reflects the growing need for translational science and for pharmaceutical scientists to remain highly competitive for research funding opportunities. As NIH Director Francis Collins, M.D., Ph.D., explained, “While NIH will most assuredly continue its strong tradition of supporting basic research, NIH will also forge a new paradigm to revolutionize the science of translation through partnership and speed up the movement of scientific discoveries from the lab to patients.” In the Summer 2012 issue of Academic Pharmacy Now, AACP Vice President of Policy and Advocacy William G. Lang, underscored the importance of intramural and extramural collaborations for securing vital resources and producing successful outcomes in the quality of research, teaching and service. According to data that AACP collected on pharmacy faculty research grants for fiscal year 2011, most of the $365 million principal investigator grants from the NIH and other federal and non-federal research grants have collaborators within or outside the institution. In addition, pharmacy faculty received nearly $50 million solely as collaborative investigators through subcontract arrangement. The National Institute for Pharmaceutical Technology and Education program, another example of a multiinstitutional collaboration, is dedicated to fundamental research and education devoted to pharmaceutical technology and discovery, product development, manufacturing and science-based regulation. This trend will likely continue as most funding agencies encourage collaborative research, which will benefit scientific discovery and health outcomes.
A Conduit for Collaboration AACP’s Office of Research and Graduate Education embraces the concept of teamwork. Its approach is to establish frameworks and programs for AACP institutional and individual members that will allow basic pharmaceutical and clinical pharmacy research investigators to connect, establish mentoring and collaborative relationships, and share ideas and resources (human, intellectual, methodology, equipment, etc.). AACP is creating a database for collecting institutional information on graduate degree programs and aggregated graduate student profiles and career outcomes that the NIH and the Council of Graduate Schools are seeking. This information will also help market graduate degree programs within pharmacy schools.
Pharmacy plays a significant role in fortifying the research pipeline, but to do so the profession must share knowledge, exchange skills and resources, and recognize accomplishments. AACP will continue publishing faculty-funded research projects and disseminating information on pharmacy and pharmaceutical-relevant research funding opportunities. Also in the works is an Academic Research Fellows Program which will not only advance participants’ research endeavors, but also allow them to mentor and form teams with colleagues from a broad range of research interests and backgrounds at their home institutions. To learn more about the Association’s research activities, visit the AACP Web site at www.aacp. org and click on Resources, then Research. Vincent Lau, Ph.D., is Vice President of Research and Graduate Education and Chief Science Officer at AACP; firstname.lastname@example.org.
Resources Draft report by the Biomedical Research Workforce Working Group http://acd.od.nih.gov/bmw_report.pdf National Center for Advancing Translational Sciences http://www.ncats.nih.gov/research/reengineering/rescue-repurpose/ therapeutic-uses/therapeutic-uses.html NIH Funding Opportunity Announcement— Collaborative Translational Research Projects http://grants.nih.gov/grants/guide/notice-files/NOT-HD-12-025.html The National Institute for Pharmaceutical Technology and Education http://www.nipte.org academic Pharmacy now Fall 2012
plex B alance
The Academy of Managed Care Pharmacy’s CEO talks about improving patient health while controlling costs. By Edith A. Rosato, R.Ph., IOM What is managed care pharmacy? It’s a simple question that often requires a complex answer…in fact, it sometimes requires several answers. The short version is that managed care pharmacy is the practice through which drug benefits are designed and delivered to more than 200 million Americans covered by health insurance. The long answer is that managed care pharmacy creates drug benefits that provide patients with broad access to medications that have been shown to be safest and most effective. At the same time, managed care pharmacy implements tools and practices that control limited resources and keep healthcare costs under control. Managed care pharmacy professionals— including pharmacists, physicians, nurses and caseworkers—perform many crucial functions to ensure the successful outcome of these goals. Common tasks include: • Monitoring the safety and effectiveness of new medications on the market. • Alerting patients and providers to potentially dangerous medication interactions. • Using medication therapy management practices to ensure patients receive the most appropriate therapies. • Developing and implementing educational programs to improve medication adherence. • Using various evidence-based tools and incentives to keep the costs of prescription drugs under control.
academic Pharmacy now Fall 2012
a n a of M
e r a C d ge
All of these practices, and more, aim to ensure that all patients can receive the medications they need to improve their health and wellbeing. Managed care pharmacy professionals who are members of the Academy of Managed Care Pharmacy (AMCP) uphold the vision of our organization, which is to “improve health care for all.”
Tied to Healthcare Reform How are decisions about the value of medications made? This task falls primarily to a health plan’s pharmacy and therapeutics committee (P&T committee). Made up of pharmacists, physicians and other healthcare professionals, P&T committees strive to determine the value of new medications by examining all available scientific data on the product. Only then do they make a recommendation as to how the health plan should position the product relative to similar therapies. The practices of the P&T committee have much in common with the 2010 Affordable Care Act, which emphasizes finding and establishing value in healthcare delivery. Managed care pharmacy is well positioned to play a major role under the new law. By 2016, an estimated 30 million individuals are expected to obtain health insurance from private health plans participating in state insurance exchanges, as well as through state expansion of Medicaid programs. These plans must contain a federally determined “essential health benefits package”—a package that requires access to prescription medications.
While managed care pharmacy applauds this provision, AMCP has asked the Department of Health and Human Services to include not only access to medications, but the management of medication therapies as well. In addition, AMCP has proposed to HHS that health plans maintain autonomy over the design of the drug benefit, as well as the determination of which medications are to be covered and deemed essential. Flexibility in making medication coverage decisions, and in designing the overall pharmacy benefit, will allow managed care organizations to incorporate a range of best practices to improve clinical outcomes and control costs.
Keeping Costs Low Managed care pharmacy professionals take seriously the need to carefully manage limited resources. And in today’s world that means they must be cognizant of costs. Some believe that managed care pharmacy focuses too much on costs, and that costs are controlled by putting up hurdles to access and burdensome restrictions on certain medications. The response to that argument is the underlying principle in managed care pharmacy: that medications are examined based on their value, not simply their sticker price. This means evaluating their overall effectiveness in improving health outcomes. In other words, it may make sense to spend extra on a particular medicine today if it will keep a patient away from a more costly hospital stay tomorrow.
academic Pharmacy now Fall 2012
Tools and Practices 101 Managed care pharmacy professionals use many tools and practices to improve patient care and control costs. Below are explanations of some of the more common ones: Step Therapy: Designed to encourage the use of therapeutically equivalent, lowercost medications (i.e., first-line therapy) before “stepping up” to more expensive therapy (i.e., second-line therapy). Prior Authorization: An administrative tool normally used by a health plan or prescription benefit management company (PBM) that requires the prescriber to receive preapproval for prescribing a drug in order for the drug to qualify for coverage under the terms of the pharmacy benefit plan. Therapeutic Interchange: Also referred to as “switch” or “conversion” programs, they encourage the use of formulary drugs by switching from one agent in a therapeutic class not on the formulary to an agent on the formulary and less expensive for the managed care organization. Drug Utilization Review: Synonymous with drug use evaluation (DUE), which is defined as an authorized, structured, ongoing review of physician prescribing, pharmacist dispensing and patient use of medication. It involves a comprehensive review of patients’ prescription and medication data before, during, and after dispensing to ensure appropriate medication decision making and positive patient outcomes. Rebates or Contracting: Mechanisms that managed care organizations can use to secure lower drug prices from pharmaceutical manufacturers as part of their effort to control drug expenditures. For more information, including a review of the scientific literature on how these practices affect healthcare delivery, read “Effect of Managed Care Pharmacy Tools: An Annotated Bibliography,” at www.amcp. org/AMCPPublications.
academic Pharmacy now Fall 2012
P&T Committees Play a Role When a new medication comes before the P&T committee with strong evidence of improved effectiveness or safety over existing therapies, the group may recommend it for a preferred tier on the drug formulary, where financial barriers to access are low. On the other hand, if a medication comes with little or no evidence showing its effectiveness over existing, less expensive products, then the P&T committee may place the new product on a higher tier, which requires more cost-sharing. Patients can still access this medication, but the placement incentivizes them to select a lower-cost option. Student pharmacists increasingly are interested in evaluations of medications based on their value, as evidenced by AMCP’s 50 student pharmacist chapters in pharmacy schools nationwide. One of the most popular activities for the chapters is the annual national P&T competition, where teams compete to make the case for inclusion of a medication on an imaginary managed care organization’s formulary.
More Opportunities for Involvement Another place where managed care pharmacy will have a role under the new reform is in the establishment of accountable care organizations. As defined by law, ACOs are networks of physicians and other providers who work together to improve the quality of healthcare services and reduce costs for patient populations. The law gives the Centers for Medicare and Medicaid Services authority to start contracting with ACOs this year. To date, however, ACO planners generally have focused on physicians and hospitals, and have failed to mention a definitive role for pharmacists. AMCP has focused on changing that oversight. In a document released last year, AMCP identified multiple examples of ACO-like organizations that incorporate pharmacists and medication therapy as an essential element. This white paper shows that pharmacists participating in team-based care models have made positive contributions to patient care and safe medication use. The pharmacist’s role is being recognized in pilot ACOs under development. In ACOs and elsewhere, pharmacists have taken on new and greater roles in providing care. You can see this in some of the model “transitions of care” efforts taking place nationwide around patients discharged from institutions. Think about it, patients are often wheeled out of a hospital with a bag full of medications and little knowledge of how to use them. According to government statistics: • one in five patients discharged from a hospital experiences an adverse event within three weeks; and • one in five Medicare patients is readmitted in 30 days.
Managed care pharmacists are addressing this problem. As part of one Massachusetts health plan, a group of pharmacists visit the homes of discharged hospital patients identified as at-risk. This project has significantly decreased readmissions and adverse events. Comparative effectiveness research is another area ripe for managed care pharmacy to play a leading role. CER initiatives are looking to use the huge databases of our member organizations. Using this de-identified data, researchers can find valuable new information on how various therapies and interventions compare. Again, the aim is to provide the best care for patients while avoiding unnecessary and ineffective treatments. AMCP is disseminating some CER findings through a grant with the Agency for Healthcare Research and Quality. You can find summaries of AHRQ’s latest CER findings at www.amcp.org.
Joint Commission of Pharmacy Practitioners AMCP and its members are continually working to build bridges to our pharmacy colleagues. Our common aims can be seen in how the pharmacy profession came together on the Joint Commission of Pharmacy Practitioners’ Future Vision of Pharmacy Practice: That document states that by 2015: Pharmacy education will prepare pharmacists to provide patient-centered and population-based care that optimizes medication therapy; to manage health care system resources to improve therapeutic outcomes; and to promote health improvement, wellness, and disease prevention. To help fulfill the goals of the JCPP, AMCP has developed a host of resources for academia, including white papers and presentations for use in the classroom. Resources include the AMCP Managed Care Pharmacy Model Curriculum; the AMCP Experiential Education Directory; Mapping Your Career in Managed Care Pharmacy: A Student Pharmacist’s Guide; Drug Payment Methodologies; and Principles in Practice series, which provides cases for use by pharmacy professors as an adjunct to didactic training of the practice of pharmacy in the managed care setting. To access these and many more resources, visit www.amcp.org/ AMCPPublications.
October 15 Deadline for Competition Registration The Foundation for Managed Care Pharmacy will hold its 13th Annual National Student P&T Committee Competition at the Academy of Managed Care Pharmacy’s 25th Annual Meeting & Showcase in San Diego, California, April 3–5. The local and national competition is intended to give student pharmacists an opportunity to gain a real world perspective of the formulary management process and to hone a variety of skills including critical analysis, presentation and research skills. The competition allows student pharmacists to view different styles and processes that can be used in effective formulary management and provide exposure to, and a working knowledge of, the AMCP Format for Formulary Submissions. New this year, the competition will use the AMCP eDossier System, an electronic platform that allows drug formulary decision makers to easily search and filter through the often voluminous amounts of information that accompany today’s medications. Only AMCP student pharmacist members are eligible to participate. The deadline for registration is Oct. 15. To register for the competition or for more information, visit www.amcp. org/FmcpCategory.aspx?id=9167.
This is an exciting time to be a pharmacist as managed care has a great opportunity to help shape the future of healthcare in this country. Edith A. Rosato, R.Ph., IOM, is chief executive officer at the Academy of Managed Care Pharmacy.
academic Pharmacy now Fall 2012
Pharmacy educators engaged in professional development on a grand scale at the 2012 AACP Annual Meeting.
By Gerry Romano, Maureen Thielemans and Kelley Ratermann Amid the variety of programs, events and participants at Pharmacy Education 2012 was one common denominator: big-time professional development. The number of attendees—1,980—set an AACP Annual Meeting record. The educational opportunities filled a tall order. And no matter where you looked, you found a friendship to forge or renew. Following are highlights of the conference, held July 14–18, at the Gaylord Palms Resort and Convention Center, in Kissimmee, Florida.
Excellence and Relevance AACP President Brian L. Crabtree, Pharm.D., opened the An- of education and research scholarship. I described significant enhancements to our research and graduate education efforts. nual Meeting with observations about the Association’s work during the past year in support of his presidential theme, Ex- Finally, I said for all to hear in a manner as conspicuous as I could summon, pharmacy is a science-based profession. cellence and Relevance. Crabtree, formerly a professor at The University of Mississippi School of Pharmacy and now chair of the Department of Pharmacy Practice at Wayne State Uni- “From the perspective of an educator whose greatest thrill and fulfillment in my career has come from teaching,” he continversity, pointed out that volunteer leaders and members “truly ued, “I have said for years that we need an academic reward brought the theme to life, making AACP an even stronger and system that matches what we say in our literature and pubmore valuable association for all of us.” lic statements, a system that rewards excellence in teaching in parity with excellence in scholarship. We aspire to excellence Crabtree reflected on the leadership agenda that he outlined a in all areas of our mission, but our people are diverse in pasyear ago: “I stated that we need a more balanced way to reward sion and talent. Some of us are better at one element of our the diversity of excellence that exists among us, especially with regard to excellence in teaching. We need to develop precep- mission than others, whether that is teaching or scholarship. tors as integral to the quality of the education we offer, provid- Excellence is worthy of reward, wherever it exists.” ing evidence-based standards of excellence which we can acCrabtree shared the charges he made to the AACP standing knowledge publicly and to which preceptors can aspire. I asked committees last year and praised their tremendous progress. for an improved balance of our advocacy portfolio in the areas [For details on this work, see the standing committee reports posted at http://www.aacp.org/governance/committees.] “Leadership matters and the president can lead,” he said, “but one thing I’ve learned is that the heavy lifting is done by the Keep Learning staff and the outstanding members who are appointed to the committees in all units of governance.
Annual Meeting session recordings are available in the AACP Online Learning Center at http://aacp. sclivelearningcenter.com. Also posted, at http:// www.aacp.org/meetingsandevents/AM/2012/Pages/ Presentations.aspx, are presentations and handouts.
academic Pharmacy now Fall 2012
“The experience of leadership in AACP has been a career highlight,” Crabtree said. “It has made me a better faculty member, plain and simple.” The session’s keynote speaker was Sir Ken Robinson, an expert on education reform and a respected adviser to governments in
Star Sightings at Annual Meeting Three Academy members were honored at the Annual Meeting for their excellence in pharmacy education and research. Read about their outstanding work in the Summer issue of Academic Pharmacy Now. Europe, Asia and the United States. Robinson enlightened and entertained the audience with his talk about the dire need for truly creative thinking at all levels of the learning continuum. “I define creativity as the process of having original ideas that have value,” he said. “And it’s a process you can teach.” “Only special people are creative: this is a myth.” He encouraged participants to “…activate your creativity. To be creative, you have to do something.”
Now it’s your turn to help us uncover outstanding contributors in those fields. Nominate an academic pharmacy colleague for one of the Association’s top awards: Robert K. Chalmers Distinguished Pharmacy Educator Award, Paul R. Dawson Biotechnology Award and Volwiler Research Achievement Award. Visit http://www.aacp.org/career/awards today.
The Annual Meeting provided an opportunity for attendees to meet up with old friends and connect with new colleagues from across the country. At the school poster session, attendees discussed the posters’ theme of interprofessionalism or interprofessionality.
academic Pharmacy now Fall 2012
Seats at the Right Tables Addressing attendees at the first session of the House of Delegates, AACP President-elect J. Lyle Bootman, Ph.D., senior vice president for health sciences and dean of the College of Pharmacy at The University of Arizona, said that he is “excited, energized and most honored by the opportunity to lead the Academy as AACP’s incoming president. As we heard Sir Ken Robinson state clearly at the opening session, the times we are in are not simple times. The issues before us require leadership, oftentimes some political skill, and bold new approaches to how we conduct research, educate and work as healthcare professionals. I am confident that AACP can play a decisive role in leading change in this dynamic era. “There has never been a more important time for academic pharmacy, and AACP specifically, to get to all the right tables of influence at the right time,” Bootman said. “We also need to continually think about building and equipping the next generation of leaders with the skills and visibility they need to be game-changers.” In support of this goal, he announced a joint partnership between AACP and the American College of Clinical Pharmacy to establish the first-ever Pharmacy Fellowship as part of the National Academies’ Institute of Medicine Anniversary Fellowship Program. “The IOM represents just one of the important tables of influence for pharmacy education in this dynamic—and some might say, chaotic—time,” Bootman continued. “As your president I will dedicate all of my energy to identifying many more opportunities for influence. I will communicate the Association’s initiatives and your outstanding work to state and national policy makers, private-sector decision makers and our colleagues across the spectrum of health professions education, research and practice. Our work can make a difference in the shared goal of creating value in healthcare.” Top: The 2011–12 AACP Board of Directors. Middle: In a report to the House of Delegates during its second session, AACP Executive Vice President and CEO Lucinda L. Maine, Ph.D., R.Ph., relayed learnings from a retreat led by Clayton Christensen, author of Innovator’s Prescription: Disruptive Innovation in Health Care and Disrupting Class. She discussed disruptive innovation and opportunity, noting Christensen’s simplified principle: “Disruptive innovation can occur when something that has historically been very complex and expensive can become much simpler and more accessible to the average consumer.” Bottom: Dr. Leigh Ann Ross (left) represented The University of Mississippi School of Pharmacy, recipient of the Lawrence C. Weaver Transformative Community Service Award, at the Examining Excellence Awards Plenary. Dr. Gene D. Morse (middle), Volwiler Research Award recipient, joined other winners on a panel to discuss what qualities mark excellence in education and research. Dr. Milap C. Nahata (right), AACP past president, moderated the dialogue.
academic Pharmacy now Fall 2012
Disruptive Innovation and Opportunity In a report to the House of Delegates during its second session, AACP Executive Vice President and CEO Lucinda L. Maine, Ph.D., R.Ph., relayed learnings from a retreat led by Clayton Christensen, author of Innovator’s Prescription: Disruptive Innovation in Health Care and Disrupting Class.“The good professor suggests clearly and passionately that both healthcare and education at all levels are poised for significant disruption,” she said. “Christensen bases all of his work on his initial study of how the computing industry has and continues to evolve disruptively. Certainly we all appreciate how advances in technology have affected—some might say now rule—our lives. If you consider the changes in the management and funding of research as also disruptive, one might realize that we in health professions education and research are at the epicenter of disruptive forces.” Maine noted Christensen’s simplified principle: “Disruptive innovation can occur when something that has historically been very complex and expensive can become much simpler and more accessible to the average consumer. “So what does this mean for AACP? I believe that one other lesson from Clayton deserves attention. In an industry being disrupted, one thing tends to be true. The predominant players in the field can rarely bring forth the disruptive innovation. …While pharmacists might be the third largest health profession numerically, we are small, with under 300,000 licensed professionals and just under 130 colleges and schools. …While small can sometimes equate to underpowered, it doesn’t have to as long as you avoid the underdog mentality. If we have a disruptive solution to bring to the table and are nimble enough as an industry to figure out how to deliver that solution in a sustainable way, then size may be our advantage.” Maine referred to president-elect Bootman’s presentation earlier in the Annual Meeting, agreeing that “now is the time to bring our leadership related to the discovery, application and evaluation of knowledge about medications and their effective use to all the right tables. To do so most effectively, we must understand the disruptive forces in our industries and work together in positioning pharmacy education and our partners in practice and research as part of the solution to building new approaches to education, research and practice. “Knowledge of disruptive forces is one tool,” she continued. “Advocacy on behalf of pharmacy education is essential as well. But there is one more element to the equation we need to have in play, and to describe this I will draw upon a blog from Gary Gunderson, now at Wake Forest University and formerly at LeBonheur Health System in Memphis. Gary’s work connects the healing community with the faith community to the advantage of all involved, especially the consumer and their caregivers. Once asked what was it that made Gary’s seven-year effort in Memphis work, he responded that major movements advance ‘at the speed of trust.’
Top and bottom: Annual Meeting attendees kept the professional development going on Monday during the exhibitors’ luncheon and final poster session. More than 40 companies and organizations showcased their products and services.
academic Pharmacy now Fall 2012
“I believe that many of our advances in pharmacy education have occurred because our relative smallness and the inclusive structure of AACP allow us, most often, to operate with a degree of trust that comes from strong relationships,” Maine commented. “Occasionally we will hit on a topic that is challenging, like changing degrees, but with adequate opportunity for dialogue about what is the right thing to do and sufficient trust, we make the right decision and move forward together to implement and succeed. I challenge you to think about that in the context of your work back home and especially in the important work unfolding in interprofessional education, research and practice.”
Thanks to Our Sponsors National Association of Chain Drug Stores Liaison International Pearson Clinical Assessment Amgen Procter & Gamble Certiphi Screening, Inc. Walmart Creighton University Examsoft Worldwide, Inc. Fairleigh Dickinson University Kaplan Medical Walgreens Teva Pharmaceuticals Florida A&M University College of Pharmacy and Pharmaceutical Sciences Lake Erie College of Osteopathic Medicine (LECOM) School of Pharmacy Bradenton Nova Southeastern University College of Pharmacy University of Florida College of Pharmacy University of South Florida College of Pharmacy
academic Pharmacy now Fall 2012
Prescription Drugs Prove Problematic The combination of two renowned speakers and a thought-provoking topic drew a large crowd to the Science Plenary. Dr. Bryan W. Brooks, professor of environmental science and biomedical studies at Baylor University, and R. Gil Kerlikowske, director of the Office of National Drug Control Policy, led an enlightening discussion about the key scientific, environmental and societal issues associated with prescription drug abuse and waste. Our environment is in jeopardy because of how we handle the disposal of excess medicine and by-products of manufacturing, Brooks asserted. He pointed out that pharmaceuticals, while essential to healthcare, are very different than other contaminants—once entered into the environment, they are a risk to the world. Still, we shouldn’t worry too much about their effects on public health. Residuals entering the ecosystem through excretion, waste water treatment plants or human disposal could be harmful, but they don’t pose a major threat in their miniscule amounts. We should be concerned, however, with the ecological impact of improper medication disposal. Brooks said that drug take-back events, in which many pharmacy schools participate, are effective in safely collecting unused medications without harming the environment. One in four people using drugs for the first time in 2010 began by using a prescription drug non-medically, Kerlikowske said. His office is tasked with establishing policies, priorities and objectives for the country’s drug-control program to reduce illicit drug use, manufacturing and trafficking, drug-related crime and violence, and drug-related health consequences. The Prescription Drug Abuse Prevention Plan provides a framework to address this growing epidemic with four focus areas: education, drug monitoring programs, proper medication disposal and enforcement. Within each area are recommendations to address a need for more education or training. For example, according to the report, 67.5 percent of pharmacists reported receiving two hours or less of addiction or substance abuse education in pharmacy school; 29.2 percent of pharmacists surveyed reported receiving no addiction education. How do we fill this education gap? Legislation requiring mandatory education for all clinicians who prescribe controlled substances as well as increased substance abuse education in health profession schools are two action items suggested in the report. There is no simple solution to the problem of prescription drug abuse, but we all have a role to play, Kerlikowske noted, especially pharmacists and pharmacy educators.
A Bright Future for Academic Pharmacy The intelligent minds of student pharmacists, residents, graduate students and their mentors—chosen as AACP Walmart Scholars for their interest in academia as a career—were on full display at the Annual Meeting. The Walmart Scholars program was created to help intensify the scholar’s desire to join the ranks of academic pharmacy and solidify the skills that every successful faculty member requires. With the growing need for qualified individuals to fill faculty positions at pharmacy schools, what better way to address the situation than by offering 75 student/faculty pairs academically tailored programming and the unparalleled ability to learn side-by-side with one another? The Walmart Scholars keystone event is the Teachers Seminar, which provided a forum for mentees and mentors to view academia from a different perspective. Several innovative additions to last year’s seminar included the incorporation of a student panel and a “flip-the-classroom” exercise. Throughout the day-long session, students were responsible for directing the discussion at their tables. Walmart Scholar Megan Austin, a student pharmacist at the University of Missouri-Kansas City, said, “Leading the discussion between members of our group allowed me to collaborate with academia professionals in a way I was not accustomed to. Flipping the roles allowed me to display my leadership skills to my superiors and gave me renewed confidence.” New advances in teaching techniques and progressive discussions about communication in today’s technology-laden classrooms played directly into the seminar’s theme, Connecting Learners and Teachers: Is There an App for That? The celebration of some of the nation’s brightest students continued throughout the Annual Meeting. Eager participants such as Jeremy Stultz, a second-year fellow at The Ohio State University, noted how he maximized the experience by attending additional sessions about technology in the classroom, Robinson’s keynote address, and the House of Delegates meetings. Elyse Weitzmann, a fourth-year student pharmacist at the University of Pittsburgh, added, “The key to success with my AACP experience was networking…I met deans, new teachers and experienced teachers. It is truly amazing and energizing to hear about the unique and oftentimes unpredictable nature of career pathways.” Gerry Romano is Director of Communications and Marketing at AACP; email@example.com. Maureen Thielemans is Communications Manager at AACP and Editor of Academic Pharmacy Now; mthielemans@aacp. org. Kelley Ratermann is a 2013 Pharm.D. candidate at the University of Kentucky; firstname.lastname@example.org.
Save the Date
Top: At the second session of the AACP House of Delegates, J. Lyle Bootman, Ph.D., was installed as 2012–13 AACP President. Bootman, senior vice president for health sciences and dean of the College of Pharmacy at The University of Arizona, accepted the gavel, succeeding Brian L. Crabtree, Pharm.D., chair of the Department of Pharmacy Practice at Wayne State University. Bottom: The conference featured a wide range of concurrent sessions on topics of key interest to pharmacy educators. In the myth-busting presentation “Publishing Is Easier Than You Think,” Julia Esparza of LSU Health Shreveport told participants to consider: “What drives your curiosity?” Once you have the answer, you’ve got a research idea—and, ultimately, a study to write about. Esparza outlined steps for getting published and said, “Don’t be intimidated by writing—anyone can do it.”
Mark your calendar for the next AACP Annual Meeting, July 13–17, in Chicago. Plans are already under way to make Pharmacy Education 2013 an outstanding event. academic Pharmacy now Fall 2012
The NACDS Foundation believes in the power of education. Please visit our website at www.nacdsfoundation.org to learn more about our academic initiatives. • • • • •
Academic Pharmacy Awards Community Pharmacy Residency Expansion Project Faculty Scholars Program Patient Care Database Student Pharmacist Opportunities
The NACDS Foundation is a proud sponsor of the 2012 AACP Interim Meeting.
Want to learn more about the NACDS Foundation? Scannow with your academic Pharmacy Fall 2012smart phone or visit www.nacdsfoundation.org.
academic Pharmacy now ď‚§ Fall 2012
Feel confident you are identifying candidates who will succeed in your pharmacy program • The PCAT is a proven predictor of successful performance in pharmacy school and on national licensure exams • Helps you make well-informed decisions • curriculum requirements • Endorsed by the American Association of Colleges of Pharmacy (AACP)
Copyright © 2012 Pearson Education, Inc. or its affiliate(s). All rights reserved. PCAT and Pearson are trademarks, in the U.S. and/or other
academic Pharmacy now Fall 2012
Faculty News Auburn University Appointments/Elections • Paul W. Jungnickel, president-elect of the Rho Chi Pharmacy Honor Society
• Anisa Fornoff was promoted to associate professor. • Carrie Koenigsfeld was promoted to the rank of professor of clinical sciences. • Erik D. Maki was promoted to associate professor.
• Jingjing Qian, assistant professor, pharmacy care systems
• Ronald J. Torry has been promoted to chair of pharmaceutical, biomedical & administrative sciences.
• Peter Panizzi received a grant for $99,468 from the National Institutes of Health for “Pathobiology of Staphylococcus aureus Endocarditis.” • William R. Ravis and Misty Edmondson (PI) were awarded a $13,215.43 grant for “Pharmacokinetics and Safety of Gabapentin after Single Intravenous and Oral Administration to Alpacas” from the Alpaca Research Foundation.
Promotions • Anne Marie Liles, associate clinical professor • Jessica Starr, associate clinical professor
• Linda L. Krypel, professor of clinical sciences, retired in May 2012.
Duquesne University Grants • Aleem Gangjee, principal investigator. Project Title: Water Soluble Antimitotics That Circumvent Tumor Resistance. Period of Project: June 1, 2011 to March 31, 2016. Source: National Institutes of Health/National Cancer Institute. Amount Granted - Year 2: $313,298. Total Award: 1,567,135.
• Ted Hancock was recently named 2012 Chronic Care Pharmacist of the Year by the North Carolina Association of Pharmacists.
• Wilson S. Meng, principal investigator. Project Title: A Biomaterial Approach to Inhibit Melanoma Growth and Metastasis in Mice. Period of Project: January 1, 2012 to December 31, 2013. Source: Commonwealth Universal Research Enhancement (C.U.R.E.) program from the Pennsylvania Department of Health. Amount Granted 11-12: $13,250. Total Grant: $53,000.
• Julie Hall received the AACP New Investigator Award, $10,000, funded proposal was titled “Endocrine Disruptors Promote Adipogenesis and Fat Storage via Activation of PPARy.”
• Hildegarde J. Berdine, professor of pharmacy practice; director, Clinical Laboratory Center for Pharmacy Care • Lawrence H. Block, professor of pharmaceutics
• Daniel Shin has been awarded a grant for $58,880 from the North Carolina Biotechnology Center, title: “Bioanalytical Equipment for Student Training (BEST).”
• Henry R. Freedy Jr., associate professor of pharmacy practice
• John G. Lech Jr., associate professor of pharmacy practice; director, Pharmaceutical Information Center
• Heather P. Whitley, associate clinical professor
Campbell University Awards
Appointments/Elections • Pramod B. Mahajan has been elected the chair of the Pharmacogenomics Focus Group of the American Association of Pharmaceutical Scientists for 2012.
• Joseph M. Kristofik, former director, experiential education
• Thomas L. Rihn, division head of clinical, social & administrative sciences; associate professor of pharmacy practice
• Michelle M. Bottenberg was promoted to associate professor.
academic Pharmacy now Fall 2012
Florida A&M University Appointments/Elections • Michael Thompson has been named the dean of the College of Pharmacy.
Midwestern University/ Downers Grove Appointments/Elections • Anil Gulati has been appointed to the International Scholarly Research Network editorial board and has also been appointed to the Journal of Blood Disorders & Transfusion editorial board. • Robin Hieber has been appointed editor of the Mental Health Clinician. • Marc Scheetz was nominated to The Joint Commission’s National Summit on Overuse. • Carrie A. Sincak has been re-appointed to the ASHP Commission on Affiliate Relations.
Awards • Carrie A. Sincak has been awarded fellow status in the American Society of Health-System Pharmacists.
Grants • Anil Gulati received a grant of $10,000 from Novo Nordisk, Inc. for organizing the Third International Symposium.
Promotions • Mary Ann Kliethermes has been awarded tenure in pharmacy practice. • Marc Scheetz has been promoted to associate professor of pharmacy practice and awarded tenure. ‘ • Justin M. Schmidt has been promoted to associate professor of pharmacy practice. • Susan R. Winkler has been awarded tenure in pharmacy practice.
Ohio Northern University Appointments/Elections • Jenelle L. Sobotka was sworn in as president of the American Pharmacists Association.
Awards • David R. Bright received the 2012 APhA Distinguished New Practitioner Award. • Allen Nichol received the 2012 APhA Academy of Pharmacy Practice and Management Distinguished
academic Pharmacy now Fall 2012
Achievement Award in Community and Ambulatory Practice. • ONU’s Raabe College of Pharmacy APhA Academy of Student Pharmacists chapter was one of five chapters in the nation to be awarded the second annual Generation Rx National Award. • The ONU APhA-ASP student chapter received the 2012 Region 4 Award for Operation Immunization.
Purdue University Appointments/Elections • V. Jo Davisson was appointed chair of the Synthetic and Biological Chemistry B Study Section, Center for Scientific Review, National Institutes of Health. • Tonglei Li has been hired as professor of industrial and physical pharmacy. He was also appointed as the Allen Chao chair in industrial and physical pharmacy.
Grants • Richard F. Borch received $44,829 from Trask Trust Fund for “TRASK: Immune Response Enhancement Using Linker-Modified Proteins.” • David A. Colby and Jean-Christophe Rochet received $186,688 from PHS-NIH National Institute on Aging for “Anthocyanins and Structural Derivatives for Drug Discover in Age-Related Neurode.” • Robert L. Geahlen received $1,663,709 from NIH for “Tyrosine Kinases and Lymphocyte Activation.” • Richard A. Gibbs received $167,475 from PHS-NIH National Institute on Deafness and Other Communication Disorders for “The Role of a Novel Vitamin E Metabolite in Colon Cancer Prevention and Therapy.” • Marlene O. Heeg received $528,350 from Amylin Pharmaceuticals, Inc. for “Long-Acting GlucagonLike Peptide-1 (GLP-1) Receptor Agonist Therapy: Improving Efficacy, Adherence, & Weight in Type 2 Diabetes Mellitus (T2DM): 2012 Americans with Disabilities Act (ADA) Symposium”; and $285,000 from Forest Laboratories for “IBS News Tonight: a Satellite Symposium at DDW 2012 and On-Demand Webcast.” • Wanqing Liu received $204,652 from PHS-NIH National Institute of Diabetes and Digestive and Kidney Diseases for “An Integrated Genomic and Lipidomic Approach to Human Hepatic Fat Accumulation.” • Sonak Pastakia received $29,994 from Celgene
Corporation for Lenalidomide and Thalidomide AMPATH Risk Management Program.” • Carol B. Post received $314,392 from PHS-NIH National Institute of General Medical Science for “Nuclear Magnetic Resonance (NMR) Structure of Peptide and Protein Complexes.” • Daniel T. Smith received $350,376 from PHS-NIH National Institute Neurological Disorders and Stroke for “Role of Acrolein in Spinal Cord Injury.” • Joseph Thomas III received $298,116 from PHS-NIH National Institute on Aging for “Prognostic Significance of Insufficient Activity of Daily Living (ADL) Help on Health Outcomes/Utilization.”
Society of Health-System Pharmacists National Skills Competition • Lindsey R. Elmore, chair of the Residency Committee of the Alabama Society of Health-System Pharmacists (2012–2013) • Gregory S. Gorman, appointed to the editorial board of the Journal of Outlook on Emerging Drugs • Michael D. Hogue, appointed to a 3-year term on the Board of Directors of the NIH Foundation for Infectious Diseases
Shenandoah University Appointments/Elections
• Karen S. Hudmon, professor of pharmacy practice
• Douglas A. Lipton, assistant dean of student affairs, Department of Pharmacy Practice
• Yaman Kaakeh, clinical associate professor of pharmacy practice
• David W. Newton was named to the editorial board of Science and Technology for the Hospital Pharmacist.
• Douglas J. LaCount, associate professor of medicinal chemistry and molecular pharmacology
• Markus A. Lill, associate professor of medicinal chemistry and molecular pharmacology • Lynne S. Taylor, professor of industrial and physical pharmacy
Retirements • Robert W. Bennett, professor of pharmacy practice, retired in July 2011. • Donald E. Bergstrom, Walther professor of medicinal chemistry, retired in December 2011. • Gary E. Isom, professor of toxicology, retired in July 2011. • David E. Nichols, professor of medicinal chemistry and molecular pharmacology and The Robert C. and Charlotte P. Anderson distinguished chair of pharmacology, retired in June 2012.
Roseman University of Health Sciences Appointments/Elections • Renee E. Coffman was appointed executive vice president for quality assurance and intercampus consistency.
Samford University Appointments/Elections
• Erin N. Adams has been selected into the 2012-13 AACP Academic Leadership Fellows Program.
Grants • Gina Peacock received a $22,000 grant from the United States Pharmacopeia (USP) for her study titled “Development and validation of a stabilityindicating HPLC method for topiramate suspension and establishment of appropriate beyond-use dates when stored refrigerated and at room temperature.”
Promotions • Marcia L. Brackbill has been promoted to professor. • Jennifer N. Clements has been promoted to associate professor.
Retirements • Mary Ann F. Kirkpatrick, associate dean of student affairs
St. Louis College of Pharmacy Awards • Clark Kebodeaux was named to the inaugural class of the National Association of Chain Drug Stores Foundation’s Faculty Scholars Program.
The University of Findlay Appointments/Elections • Katherine Cochran was named assistant director of experiential education.
• Kimberly W. Benner, co-coordinator of the American
academic Pharmacy now Fall 2012
• Cynthia Fitzpatrick was named president-elect of the UF Phi Kappa Phi honor society. • Andrew J. Hvizdos was named associate professor of pharmacy practice. • Shankar Lanke was named assistant professor of pharmaceutical sciences. • Ryan A. Schneider was named assistant professor of pharmaceutical sciences.
Awards • Debra Parker was named the College of Pharmacy Teacher of the Year. • The College of Pharmacy was awarded $190,000 for student scholarships through the Choose Ohio First grant.
Promotions • Patrick M. Malone was granted tenure. • Debra Parker was granted tenure and promoted to associate professor of pharmacy practice. • Arindam Basu Sarkar was granted tenure and promoted to associate professor of pharmaceutical sciences. • M. Chandra Sekar was granted tenure. • Bradley Shinn was granted tenure. • Alexander Vaglenov was granted tenure.
The University of Georgia Appointments/Elections • James V. Bruckner served as the chair of a committee that reviewed the scientific merits of a U.S. EPA IRIS document that serves as the basis for setting human exposure standards to 1,4-dioxane. • Brian S. Cummings was appointed as the new director of the UGA Interdisciplinary Toxicology Program and inducted into the UGA Teaching Academy. • J. Russell May served as an ASHP site surveyor for the accreditation of the PGY-1 Residency Training Program at the VA Gulf Coast Joint Ambulatory Care Center in Pensacola, Florida. • Merrill Norton was selected as an inaugural member of the Georgia Prescription Drug Abuse Prevention Collaborative Steering Committee. • Bradley G. Phillips was elected as treasurer of the Board of Regents of the American College of Clinical Pharmacy, effective in fall 2012.
academic Pharmacy now Fall 2012
Awards • Michael G. Bartlett has been named a fellow of the American Association of Pharmaceutical Scientists. • Aaron Beedle has been named a Lilly teaching fellow by UGA’s Center for Teaching and Learning. • Susan C. Fagan was appointed to the editorial board of Stroke (Journal of the American Heart Association). • Dee Dee McEwen is one of two UGA faculty selected to receive the 2012 Service-Learning Teaching Excellence award. • Beth Phillips was named Teacher of the Year for 2012.
Grants • Robert D. Arnold, AS CO-I received 40% share for academic effort toward $46,830 grant from GraysonJockey Club Research on “Liposomal Gentamicin for the Treatment of R. Equi.” • Paul J. Brooks received $2,993 from Pfizer Inc. for Disease Management 101-A Primer to Understanding the Disease Management Process. • James V. Bruckner received $61,985 from the Consumer Specialty Product Association for equipment maintenance in the study of the characterization of potential age-related differences in the pharmacokinetics of pyrethroids in vivo, in situ and in vitro studies in rats and human systems. • Brian S. Cummings received $23,934 from Chevron Chemical Company for toxicity of ligand and metalligand=based anti-cancer agents. • Azza El-Remessy received $315,000 for the first year of funding on a five-year RO1 grant from the National Institutes of Health to study the molecular mechanisms of diabetic retinopathy (DR). The grant is expected to continue at an additional $315,000 per year, for an overall total of $1,575,000. • Susan C. Fagan received $274,729 from the National Institutes of Health for continued study of mechanisms of vascular protection after ischemic stroke; received $7,406 from the Health University of Texas continuing Parkinson’s clinical trial-statistical center; and $20,827 from the Veteran’s Administration Medical Center for study of mechanisms and consequences of hypertension after stroke - IPA for ISRAT. • Rajgopal Govindarajan received $50,000 from Georgia Research Alliance for “LET-7 Regulation of Ribonucleotide Reductase and Chemoresistance in Pancreatic Cancer.”
• Shelley Hooks received $75,000 from Marsha Rivkin Center for Ovarian Cancer for “Silencing the Suppressor: How do ovarian cancer cells shut down expression of RGS protein tumor suppressors to promote cancer progression?” • Dexi Liu transferred two NIH grants from the University of Pittsburgh: “Image-guided Hydrodynamic Gene Delivery,” is from the National Institute of Biomedical Image and Bioengineering and was awarded for the development of an image-guided, site specific gene delivery system. This grant is in its fifth year and has an annual budget of $613,572. The second grant, “Computer-Assisted Hydrodynamic Gene Delivery for Hemophilia Gene Therapy,” is an RO1 grant from the National Heart, Lung and Blood Institute for the demonstration of the safety and effectiveness of an image-guided, computer controlled injection device for treatment of hemophilia, using dogs as an animal model. The grant is in its third year and has an annual budget of $903,271. The projected budget for 2013-2014 is $324,000. • Lakshman Segar will receive $1,113,682 in funding over the next three years to study the role of plateletderived growth factors (PDGF), insulin and glucose transporters on the phenotypic characteristics of vascular smooth muscle cells (VSMCs). The RO1 grant from the National Institutes of Health/National Heart, Lung and Blood Institute was funded two years ago when Segar was a faculty member at Pennsylvania State University College of Medicine; he transferred the remaining $1.1M to the college after he joined the faculty last year. • Han-Rong Weng had been principal investigator on a four-year RO1 National Institutes of Health grant at the University of Texas M.D. Anderson Cancer Center. He was able to transfer $583,638 of the grant for the last two years of his study on glial-cytokineneuronal interactions in neuropathic pain. • Catherine A. White has been awarded a 2012 University of Georgia Innovation Instruction Faculty Grant in the amount of $5,000. • The College of Pharmacy was among 126 institutions to receive scholarships through the NACDS 2012 Pharmacy Partners Scholarship Program. The college’s $10,000 scholarship was among the largest six awarded.
Promotions • David L. DeRemer, clinical associate professor
• Deborah L. Elder, clinical associate professor • Beth Phillips, clinical professor
The University of Montana Grants • Celine Beamer Shepherd has been awarded $425,125 from NIH for Fate and Effects of Nano Materials in the Gastrointestinal Tract.
The University of Oklahoma Appointments/Elections • Jeremy L. Johnson earned board certification in advanced diabetes management (BC-ADM). • Katherine O’Neal earned board certification in advanced diabetes management (BC-ADM).
Awards • JoLaine R. Draugalis received an honorary doctorate of business and industry from Ferris State University. • Melissa S. Medina is a recipient of an OUHSC Presidential Professorship. • Michael J. Miller, 2012 APhA Fellow
Grants • Randle M. Gallucci, NIH R03 grant, “Dematological effects of gulf oil.” 2-year grant through NIEHS. • Anne Pereira, OCAST Health Research Grant, $135,000; “Role of CAP37 in neuroinflammation: Friend or foe.”
Retirements • Elgene W. Jacobs, associate professor, Department of Pharmacy: Clinical and Administrative Sciences-OKC.
The University of Tennessee Appointments/Elections • Stephan L. Foster was inducted into the National Academies of Practice. • Brandi Franklin, assistant professor in health outcomes and policy research • Christina A. Spivey, assistant professor in the Department of Clinical Pharmacy
Awards • Bradley A. Boucher has been recognized by the American College of Clinical Pharmacy as authoring one of the top 10 articles published in the ACCP Journal Pharmacotherapy during 2011.
academic Pharmacy now Fall 2012
• Lawrence M. Brown was honored as a fellow this year by the American Pharmacists Association. • William Edward Evans is the recipient of the 2012 Remington Honor Medal, the highest honor bestowed by the American Pharmacists Association. • Jeanne Ezell was presented with the Harold N. Godwin Leadership Legacy Award at the annual ASHP Midyear Clinical Meeting in December. • Shannon L. Finks received The University of Tennessee Alumni Association Outstanding Teachers Award for the College of Pharmacy. • Andrea S. Franks and Duane Miller received The University of Tennessee Health Science Center Student Government Association Executive Committee Excellence in Teaching Awards from the College of Pharmacy. • Vivian S. Loveless is the recipient of the 2012 APhA Academy of Pharmacy Practice and Management William H. Briner Distinguished Achievement Award in Nuclear Pharmacy Practice. • J. Aubrey Waddell received the Dean’s Award for Lifetime Achievement from the University of Arkansas for Medical Sciences College of Pharmacy. • Junling Wang received The University of Tennessee Health Science Center Student Government Association Executive Committee Excellence in Teaching Award from the College of Graduate Health Sciences.
Grants • John K. Buolamwini, National Institute of General Medical Sciences, National Institutes of Health; $1,107,890. A Targeted Preemptive Approach to Addressing Mitochondrial Toxicity of Nucleoside. • Wei Li, Office of the Director, National Institutes of Health; $325,000. Instrument grant for a stateof-the-art quadruple time-of-flight (Q-TOF) highresolution mass spectrometer.
Retirements • Max D. Ray, professor of pharmaceutical sciences in the health outcomes and policy research division, retired from the College of Pharmacy after five years of service.
The University of Texas at Austin Appointments/Elections • Andrea C. Gore is slated to become the next editorin-chief of Endocrinology.
Touro University California Awards • Alison McCormick is the recipient of a Gates Foundation Grand Challenges Explorations grant. She will receive $100,000 to establish “proof of concept” for her research project titled “Plant-Produced Synthetic RNA Vaccines.”
University at Buffalo, The State University of New York Awards • Gene D. Morse received the 2012 AACP Volwiler Research Achievement Award. • Gina M. Prescott received the 2012 UB School of Pharmacy and Pharmaceutical Teacher of the Year Award. • Ashley Webb received board certification as clinical toxicologist with the title: Diplomat of the American Board of Applied Toxicology.
Grants • Javier G. Blanco received a $21,507 grant from Buffalo Clinical and Translational Research Center “Anthracycline-related cardiomyopathy in breast cancer patients: Impact of Carbonyl Reductase 3 Genotype Status on Echocardiographic Measurements of Cardiomyopathy” from March 1, 2012 February 28, 2013.
Remember to submit your Faculty News today! It’s fast and easy to make sure your college or school of pharmacy is featured in the Faculty News section of Academic Pharmacy Now. Visit the AACP Web site at www.aacp.org and complete the School News Submission Form on the News and Publications portion of the Web site.
Issue Closing Date Spring 2013 Summer 2013
December 17, 2012 March 15, 2013
academic Pharmacy now Fall 2012
Promotions • Ho-Leung Fung, distinguished professor
section editor for Cardiology for the ACCP Pharmacotherapy Self Assessment Program.
University of Arkansas for Medical Sciences
• Connie A. Valdez received the 2012 Chancellor’s Teaching Recognition Award.
• Stephanie Gardner was named an American Council on Education fellow.
Promotions • Marjan Boerma was promoted to associate professor of pharmaceutical science with tenure. • Schwanda K. Flowers was promoted to associate dean of student affairs and faculty development. • Amy M. Franks was promoted to chair of the Department of Pharmacy Practice. • Howard Hendrickson was promoted to associate professor of pharmaceutical science with tenure. • Chenghui Li was promoted to associate professor of pharmaceutical science with tenure. • Kathryn K. Neill was promoted to assistant dean of experiential education.
Retirements • Charles K. Born, professor of pharmaceutical sciences, retired from the college in May 2012.
University of California, San Francisco Appointments/Elections • Joseph Guglielmo has been appointed interim dean of the School of Pharmacy.
University of Cincinnati Grants • Giovanni M. Pauletti, Dow Corning Corporation, $141,215, to support research “In Vitro Permeation Properties of Polymethylsiloxanes.”
Retirements • Robert W. Draeger, assistant professor of clinical pharmacy
University of Colorado Appointments/Elections • Robert L. Page II was recently appointed by the leadership of the American Heart Association to represent the organization at USP. Page was also selected
• Douglas N. Fish received the 2012 President’s Excellence in Teaching Award.
Promotions • David C. Thompson recently accepted the position of associate dean for academic affairs.
University of Illinois at Chicago Awards • Adam Negrusz became a diplomate of the American Board of Forensic Toxicology. • Suzanne Soliman, along with colleagues from three other universities, is a recipient of the 2012 AACP Rufus A. Lyman Award.
Grants • Xiaolong He received a one-year award from the American Cancer Society, Illinois division. His project “Functional Significance of CDC42 Alternative Splicing in Ovarian Cancer” began on June 1. • Jeremy Johnson received an American Cancer Society grant for his project “Prostate Cancer Chemoprevention with Carnosol by Dual Disruption of AR/ ER.” The four-year award began on July 1. • The UIC College of Pharmacy’s Institute for Tuberculosis Research has received three two-year grants through the National Institute of Allergy and Infectious Disease to investigate new therapeutic treatments for tuberculosis. Faculty members involved include Larry Klein, Birgit Jaki and Scott G. Franzblau.
Retirements • Ronald L. Koch, associate professor of pharmaceutics, Department of Biopharmaceutical Sciences • Anne M. Kuchta, clinical assistant professor, pharmacy practice
University of Kentucky Grants • David Feola received a five-year, $1.8 million grant from the National Institutes of Health to continue his research investigating immune responses in the lungs that will potentially lead to the discovery of medical
academic Pharmacy now Fall 2012
treatments for patients with cystic fibrosis and other chronic pulmonary inflammatory conditions.
University of Maryland Appointments/Elections • Heather B. Congdon was accepted into AACP’s Academic Leadership Fellows Program. • Jeffrey P. Gonzales has been appointed chair of the Proposal and Grants Review Committee of the Critical Care Pharmacotherapy Trials Network. • Amy L. Ives was appointed to the Eastern States Residency Advisory Board. • Cherokee Layson-Wolf has been named the school’s assistant dean for experiential learning. She has also been appointed as a pharmacist specialist member to the Specialty Council on Ambulatory Care Pharmacy with the Board of Pharmaceutical Specialties for a 3-year term. • David S. Roffman has been appointed to the Practice Analysis Taskforce in Cardiology for the Board of Pharmacy Specialties. • Paul S. Shapiro has been named the department’s vice-chair for academic affairs. • Toyin S. Tofade has been named the school’s associate director for experiential learning and has joined the Department of Pharmacy Practice and Science as an associate professor. • Sudha Veeraraghavan has been named graduate program director of the Department of Pharmaceutical Sciences.
Awards • Fred Abramson was named a Preceptor of the Year by the school’s graduating Class of 2012. He also received the Seidman Distinguished Achievement Award from the Maryland Pharmacists Association. • Robert S. Beardsley received the Noel B. Flynn Alumni Achievement Award from Oregon State University College of Pharmacy. • Amy Davidoff, Bruce Stuart, Thomas Shaffer and Sammy Shoemaker received the 2011 John M. Eisenberg Article of the Year Award from the journal Health Services Research. • Susan C. dosReis was selected as a finalist for the Public Health Systems Research Article of the Year Award, sponsored by the Robert Wood Johnson Foundation and selected by AcademyHealth.
academic Pharmacy now Fall 2012
• Suzanne Doyon received first place in the Maryland Health Data Innovation Contest. • Stuart T. Haines received the 2012 B. Olive Cole Honorary Alumnus Award from the School of Pharmacy’s Alumni Association. • Stephen W. Hoag and James E. Polli have been awarded a European patent for “Drug Authentication” for a method to evade and detect counterfeit drug products. • Amy L. Ives and Cherokee Layson-Wolf received the AACP/National Community Pharmacists Association Medication Adherence Educator Challenge Award. • Maureen A. Kane was named the school’s AACP Teacher of the Year. • Mary Lynn McPherson has been awarded fellow status from the American Society of Pain Educators and the American Society of Consultant Pharmacists. She also received the Mentor of the Year Award from the Maryland Pharmacists Association. • Robert J. Michocki was named Teacher of the Year by the school’s graduating Class of 2012. • Frank Palumbo received the Distinguished Alumnus Award from the Medical University of South Carolina. • Sudha Veeraraghavan received a United States Patent for “Mutant proline and arginine rich peptides and methods for using the same.” • Julie M. Zito has been named a fellow of the International Society for Pharmacoepidemiology.
Grants • Amy Davidoff received $165,839 from Celgene Corporation for “Effects of Active Therapy for Myelodysplastic Syndromes Compared to Supportive Care on Transfusion Dependence, Disease Progression and Survival.” • C. Daniel Mullins received $151,109 from the National Pharmaceutical Council for “Heterogeneous Treatment Effect: DNA vs MSA.”
Retirements • David A. Knapp, a professor of pharmaceutical health services research and former dean of the School of Pharmacy, has retired after 41 years of service.
University of Maryland Eastern Shore Appointments/Elections • Dana Fasanella, assistant professor • Robert A. Freeman, professor • William Harbester, assistant professor • Gretchen I. Riker, assistant professor • Hoai-An Truong, associate professor, assistant dean for professional affairs
tion of cationic lipids with dendritic cells,” $292,148; National Cancer Institute, “LPD nanoparticles in anti-cancer therapy,” $292,520; and National Cancer Institute, “Novel nanoparticles for siRNA delivery,” $238,594. • Frederico Innocenti, National Institute of Diabetes, Digestive and Kidney Diseases, “Change of Grantee Institution: Genome-wide SNP genotyping and expression analysis in human livers,” $353,696. • Rudolph L. Juliano, National Cancer Institute, “Intracellular Trafficking of Antisense and siRNA Oligonucleotides in Cancer Cells,” $307,100.
• Angela D. Kashuba, Janssen Services, L.L.C., “GCRC-2694 A Phase IV, Open Label Study in Healthy Male Subjects to Investigate,” $13,500; and Eastern Virginia Medical School, “Assessing the Effect of Contraception and the Menstrual Cycle on Pharmacokinetics, Pharmacodynamics, and Vaginal Safety in Tenofovir Vaginal Gel Users,” $160,538.
• Peixuan Guo, William Farish endowed chair of nanobiotechnology, Department of Pharmaceutical Sciences and Markey Cancer Center
• Sam Lai, National Institute of Allergy and Infectious Diseases, “Trapping HIV in mucus with IgG antibodies,” $219,709.
• Shawn Hingtgen, assistant professor
• David S. Lawrence, National Cancer Institute, “Signaling Network Dynamics in Metastatic Prostate Cancer,” $411,004; and David Lawrence, Albert Einstein College of Medicine, “Light Activated Gene Expression in Single Cells,” $114,532.
• Mark Freebery, assistant dean of experiential education
University of North Carolina at Chapel Hill
• Eugene Muratov, research assistant professor • Philip T. Rodgers, clinical associate professor, assistant dean for pharmacy practice partnerships • Jon Thorson, director, Center for Pharmaceutical Research and Innovation, and professor, Department of Pharmaceutical Sciences
Grants • Stephen C. Dedrick, Otsuka America Pharmaceutical, Inc, “The Clinical Pharmacist’s Role in Hyponatremia: Utilizing Evidence and Experience with Emerging Therapeutics,” $228,116. • Julie Dumond, National Institute of Allergy and Infectious Diseases, “Optimizing Antiretroviral Use in Aging: Pharmacokinetics, Response, and Toxicity,” $109,239.00. • Stephen V. Frye, SAIC-Frederick Inc, “Task Order #8- BOA under 5-58589 as a Comprehensive Chemical Biology Screening Center- (Master (BOA) Agreement IPF#09-5399),” $257,258; SAIC-Frederick Inc, ROR2, $387,718.00; and North Carolina Biotechnology Center, “Acquisition of a Tecan EVO 200 Robotic Sample Processor for UNC-CH CICBDD,” $200,000. • Leaf Huang, National Cancer Institute, “Interac-
• Jian Liu, National Institute of General Medicine Science, “Enzyme-Based approach to probe the specificity of heparanase and its inhibitor,” $33,099; and Michigan State University, “Synthesis of Homogeneous Heparan Sulfate Proteoglycans,” $40,000. • Kris Patterson, GlaxoSmithKline, Inc, “116195 Phase I, Open-Label Study in Healthy Male Subjects Describing GSK1349572 Exposure in Blood Plasma, Seminal Fluid and Rectal Mucosal Tissue Following Single and Multiple Dosing of GSK1349572,” $54,461.27. • Philip C. Smith, National Institute of Environmental Health Sciences, “Quantitative Proteomics for Transporters and UGTs for NIEHS,” $20,000. • Michael J. Wagner, NIH National Heart, Lung, and Blood Institute, “Genome-Wide Association of ACCORD Lipid Trial,” $716,667. • Xiao Xiao, National Institute of Diabetes, Digestive and Kidney Diseases, “Muscle as a platform for type 2 diabetes treatment by gene delivery,” $329,300.
academic Pharmacy now Fall 2012
• Yue Xiong, SAIC-Frederick Inc, “Task Order#4BOA under 5-58589 as a Comprehensive Chemical Biology Scree,” $1,136,995. • William C. Zamboni, University of Pittsburgh, “A New Dimension in Renal Clearance Design Criteria for Dendrimer Nanostructures,” $3,000.
Promotions • Susan J. Blalock, professor • Michael Jay, chair of the Division of Molecular Pharmaceutics
University of Pittsburgh Appointments/Elections • Irene M. Gathuru, instructor of pharmacy and therapeutics • Lauren J. Jonkman has been elected chair of the Pittsburgh Schweitzer Fellows Program advisory board. • Stephanie Harriman McGrath was elected to the Pennsylvania Pharmacists Board of Directors as director of chain pharmacy. • Tara L. Pummer was elected chair of the Pennsylvania Pharmacists Association editorial review board for a two-year term. • Michael A. Shullo was elected vice chair/chairelect of the Pharmacy and Pharmacology Council of the International Society of Heart and Lung Transplantation. • Susan J. Skledar was invited to serve as one of four expert mentors for the 2012 Mentored Adult Immunization Impact Program.
Awards • Neal J. Benedict received the School of Pharmacy 2012 Preceptor of the Year Award. • Jan H. Beumer has been selected as the recipient of the 2011 University of Pittsburgh Cancer Institute Junior Scholar Award in Clinical Cancer Research. • Tanya J. Fabian has been selected by the Pitt Alumni Association as the winner of the 2012 Ivan and Mary Novick Award for Young Alumni Leadership. • Karen Steinmetz Pater received the school’s Rho Chi Innovation in Teaching Award. • James J. Pschirer was selected by the Class of 2012 as the recipient of the School of Pharmacy Stanford I. Cohen Teacher of the Year Award.
academic Pharmacy now Fall 2012
• Christine M. Ruby was awarded the American Society of Consultant Pharmacists Leadership in Education Award for her innovative educational efforts in interprofessional geriatric education. • Kristine S. Schonder received the school’s Rho Chi Outstanding Scholarly Contribution Award. • The School of Pharmacy has been selected as a 2012 winner of the AACP Award for Excellence in Assessment. The award application was submitted by Susan M. Meyer and Denise L. Howrie.
Grants • Chibueze A. Ihunnah, a graduate student who works with Wen Xie, received a $64,706 fellowship grant from the National Institutes of Health as the winner of the Ruth L. Kirschstein National Research Service Award for “Estrogen Sulfotransferase in Human Adipogenesis.” • Yong Tae Kwon received a $1,488,137, four-year grant from the National Institutes of Health for “Role of Ubiquitin in Cardiovascular System.” • Melissa A. Somma McGivney received a $41,840 grant from the National Association of Chain Drug Stores for “Community Pharmacy Faculty Scholars Program.” • Ty A. Ridenour received a $120,877 grant from the Staunton Farm Foundation for “Screening During Well-Child Checkups for Older Children at Risk for Substance Abuse.” • Amy L. Seybert and Janet Lindner received a $40,000 pharmacy residency expansion grant from the American Society of Health-System Pharmacists Foundation to expand the existing critical care residency for the 2012-13 training year. • Pamela L. Smithburger received the 2012 American Society of Health-System Pharmacists Foundation New Investigator Research Grant Award for $19,924 for “A Multicenter Evaluation of Off-Label Medication Use and Adverse Drug Event in Adult Intensive Care Unit Patients.” • Michael A. Zemaitis is co-investigator on a grant from the National Institutes of Health Pain Consortium.
Promotions • Jan H. Beumer and Thomas D. Nolin, full membership in graduate faculty • Scott R. Drab, associate professor of pharmacy and therapeutics
• Song Li, professor of pharmaceutical sciences • Janice L. Pringle, associate professor of pharmacy and therapeutics
University of Washington Awards • Jashvant D. Unadkat has started a new venture at the UW School of Pharmacy—the UW Research Affiliates Program on Transporters.
Grants • Kelly K. Lee has been awarded a $1.45 million grant from the National Institutes of Health to study some of the more elusive but fundamental aspects of influenza virus membrane fusion.
Promotions • Sean D. Sullivan has been named the Stergachis Family endowed professor and director. • Kenneth E. Thummel has been named the Milo Gibaldi endowed chair of pharmaceutics.
Virginia Commonwealth University Appointments/Elections
• Gretchen M. Brophy, co-PI; Astellas Pharma; $125,000; “Sodium Management in Patients With Acute Neurological Injury.” • Richard A. Glennon, co-PI; National Institutes of Health; $2.5 million; “Syntheticcathinones: A New Class of Illicit Drugs Affecting DAT and SERT” • Kelly Goode and Leticia R. Moczygemba; Tennessee Pharmacists Research and Education Foundation; $20,000; “The Evaluation of a Pharmacy-Based Collaborative Diabetes Management Program.” • Sallie D. Mayer, co-director; VCU Exemplary Partnership in Service Award and Currents of Change Award; “Una Vida Sana! Assessing and Improving the Health Status of Richmond’s Hispanic Community Through Health Professional Student Service-Learning.” • Patricia W. Slattum, co-director; VCU Council for Community Engagement; “Community Health and Wellness Program for Older Adults.”
Retirements • William R. Garnett, professor, Department of Pharmacotherapy and Outcomes Science
Wayne State University
• Jeffrey C. Delafuente is president-elect of the American Society of Consultant Pharmacists and will be installed as president in November 2013.
• Dave L. Dixon is a member of the Patient Adherence Subcommittee, National Lipid Association, and executive council member and VCU liaison for American College of Cardiology (Cardiac Care Associates, Virginia Chapter).
Western University of Health Sciences
• Veronica P. Shuford is director of educational innovation and assessment for the dean’s office. • Patricia W. Slattum is chairwoman of the Commonwealth of Virginia Alzheimer’s and Related Disorders Commission.
Awards • Sharon S. Gatewood was named one of five 2012-13 faculty scholars by the National Association of Chain Drug Stores Foundation.
• Brian L. Crabtree, chair of the Department of Pharmacy Practice
Appointments/Elections • Hyma P. Gogineni, assistant professor of pharmacy practice and administration • Emmanuelle Schwartzman was elected Region 8 Councilor for the Rho Chi Honor Society.
Awards • Patrick Chan received the WesternU Teacher of the Year Award. • Janice Hoffman has been awarded the fellow of the American Society of Consultant Pharmacists.
• Laura A. Morgan received the Faculty Award for Excellence in Teaching.
• Cynthia Jackevicius served as a visiting professor to Kobe-Gakuin University in Japan.
• Mark Nguyen received the WesternU Preceptor of the Year Award.
• Donald F. Brophy; Department of the Army; $2.5 million; “Defining Platelet Function During Polytrauma.”
academic Pharmacy now Fall 2012
• Craig Cooper, assistant professor of critical care
Appointments/Elections • Daniel S. Longyhore was elected chair-elect to the ACCP Ambulatory Care PRN. • Adam C. Welch is acting chairperson of the Department of Pharmacy Practice for the 2012-2013 academic year.
Awards • Edward F. Foote was awarded a one year sabbatical to work on interprofessional education with The Commonwealth Medical College.
Emerging Colleges and Schools Roosevelt University
• Melissa Hogan, associate professor of clinical sciences and co-director of the professional labs • Paiboon Jungsuwadee, assistant professor of pharmacology • Matthew Nelson, assistant professor of internal medicine • Paul Ornstein, associate professor of medicinal chemistry • Prashant Sakharkar, assistant professor of social and administrative sciences
Awards • The College of Pharmacy will appear as an Outstanding Design in the August 2012 American School & University Educational Interiors Showcase.
Appointments/Elections • Shameem Aadam, assistant professor of ambulatory care
Clinical Pharmacy Faculty Position & Assistant/Associate Dean for Admissions and Outreach Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego The Skaggs School of Pharmacy and Pharmaceutical Sciences (SSPPS) within Health Sciences at UC San Diego is committed to academic excellent and diversity within the faculty, staff, and student body and is seeking candidates for a combined clinical faculty and assistant or associate deanship position depending on administrative experience. The faculty appointment is open at the associate or full professor levels based on prior academic experience of the candidate. The deanship responsibilities will include activities related to admissions (e.g. recruitment, interviewing, and selection of pharmacy students) and outreach activities to university and community groups to promote the profession of pharmacy to prospective students and the community in general. The successful candidate will be expected to teach and continue to pursue their clinical, creative or research activities as appropriate for their discipline. Qualified candidates must have a doctorate or appropriate professional degree, demonstrated excellence in interpersonal communication skills, experience and demonstrated competence in teaching of pharmacy and/or other professional students. Preference will be given to candidates with experience in admissions administration, and a strong record of creative accomplishments related to research and/or clinical practice sufficient to qualify for appointment at the associate or full professor level. Successful candidates will demonstrate strong or potential accomplishments in areas contributing to diversity, equity and inclusion, and a desire to play a leadership role in advancing UC San Diego’s commitment to achieving excellence and diversity. Salary, appointment level and series will be commensurate with qualifications and experience, and based on published UC pay scales. Review of applications will begin August 1, 2012 and will continue until the position is filled. Candidates are invited to submit a detailed curriculum vitae, a summary of experience related to administrative admissions, teaching, clinical practice, and research activities, and the names and contact information for at least three references and separate personal statement summarizing past or potential contributions to diversity (see http://facultyequity.ucsd.edu/Faculty-Applicant-C2D-Info.asp for further information) to: Jan Hirsch, PhD, Chair of Search Committee for Assistant/Associate Dean/Clinical Faculty, email@example.com. Please reference advertisement AACP2012. UCSD is an Affirmative Action/Equal Opportunity Employer with a strong institutional commitment to excellence through diversity academic Pharmacy now Fall 2012 42
Pharmacy Graduating Student Survey: Required Interprofessional Education The Graduating Student Survey was available for online access in the AACP Centralized Survey System on March 5, 2012. As of July 2012, 105 out of 110 (95.5%) colleges and schools of pharmacy graduating students in 2012 administered the survey to their students. A total of twelve thousand, one hundred and eighteen (12,118) graduating students were invited to complete the survey. Eight thousand, six
hundred and ninety-two (8,692) graduating students submitted the survey for a total response rate of nearly seventy-two percent (71.7%). Response rates per school ranged from 14.6 percent to 100.0 percent. For more information regarding this summary report or the administration of the survey, please contact Danielle Taylor, associate director of institutional research and effectiveness (firstname.lastname@example.org).
What required curricular activities (didactic or experiential) did you participate in where you had the opportunity to learn with other health professions students? Lectures
Patient-centered case problems
Active engagement with patients
Community projects, service learning
1798 Team skills training
Indicate the degree to which you agree or disagree with these statements:
The learning experience with other professions students helped me gain a better understanding of how to be part of a multi-disciplinary team to improve patient outcomes.
Research or Capstone projects
Did not participate in any required interprofessional education activities
Strongly Agree 33.6% (2923)
Agree 46.4% (4033)
2000 3000 4000 5000 6000 7000 8000
With which other professions students have you had the opportunity to participate or interact in required educational activities as indicated above? 996 Dentistry
Unable to Comment 13.8% (1202)
1110 Occupational therapy
2358 Osteopathic medicine (DO)
4086 Allopathic medicine (MD)
Strongly Disagree 1.6% (142)
1798 Physical therapy
Disagree 4.5% (392)
3073 Physician assistant
983 Public Health
1949 Social work
481 Other 481 Did not participate in any required interprofessional education activities
6000 academic Pharmacy now ď‚§ Fall 2012
American Association of Colleges of Pharmacy Discover · Learn · Care : Improve Health
1727 King Street · Alexandria, VA 22314 p: 703-739-2330 · f: 703-836-8982 · www.aacp.org For address change, please return mailing label with current school affiliation.
American Pharmacy Educator
shape the future of tomorrow’s healthcare…today!
Creativity Knowledge Mentorship Passion Discover
October 22–26, 2012
Published on Sep 28, 2012